Expanded Mesenchymal Stromal Cells in knee osteoarthritis: A systematic literature review

array:24 ["pii" => "S2173574321001106" "issn" => "21735743" "doi" => "10.1016/j.reumae.2020.10.001" "estado" => "S300" "fechaPublicacion" => "2022-01-01" "aid" => "1488" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología" "copyrightAnyo" => "2020" "documento" => "article" "crossmark" => 1 "subdocumento" => "rev" "cita" => "Reumatol Clin. 2022;18:49-55" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S1699258X20302448" "issn" => "1699258X" "doi" => "10.1016/j.reuma.2020.10.007" "estado" => "S300" "fechaPublicacion" => "2022-01-01" "aid" => "1488" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología" "documento" => "article" "crossmark" => 1 "subdocumento" => "rev" "cita" => "Reumatol Clin. 2022;18:49-55" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "es" => array:13 [ "idiomaDefecto" => true "cabecera" => "Revisión" "titulo" => "Tratamiento de la artrosis de rodilla con células mesenquimales estromales expandidas: revisión sistemática de la literatura" "tienePdf" => "es" "tieneTextoCompleto" => "es" "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "49" "paginaFinal" => "55" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Expanded Mesenchymal Stromal Cells in Knee Osteoarthritis: A Systematic Literature Review" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 2256 "Ancho" => 2167 "Tamanyo" => 207375 ] ] "descripcion" => array:1 [ "es" => "Diagrama de flujo." ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Paloma Álvarez Hernández, José de la Mata Llord" "autores" => array:2 [ 0 => array:2 [ "nombre" => "Paloma" "apellidos" => "Álvarez Hernández" ] 1 => array:2 [ "nombre" => "José" "apellidos" => "de la Mata Llord" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2173574321001106" "doi" => "10.1016/j.reumae.2020.10.001" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574321001106?idApp=UINPBA00004M" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X20302448?idApp=UINPBA00004M" "url" => "/1699258X/0000001800000001/v1_202201120658/S1699258X20302448/v1_202201120658/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S2173574321000745" "issn" => "21735743" "doi" => "10.1016/j.reumae.2020.07.012" "estado" => "S300" "fechaPublicacion" => "2022-01-01" "aid" => "1463" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Reumatol Clin. 2022;18:56-8" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "Case Report" "titulo" => "Digital ischemia as the initial presentation of catastrophic antiphospholipid syndrome" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "56" "paginaFinal" => "58" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Isquemia digital como forma de presentación de síndrome antifosfolípido catastrófico pediátrico" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1449 "Ancho" => 1750 "Tamanyo" => 238976 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0005" "detalle" => "Fig. " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "Digital ischaemia at onset and its evolution after treatment. A and B) Digital ischaemia and vasculitic lesions on palms of hands at onset. C and D) Improvement after one month of treatment." ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Laura Martín Pedraz, Rocío Galindo Zavala, Francisco Nieto Vega, Irene Sánchez Bazán, Esmeralda Núñez Cuadros" "autores" => array:5 [ 0 => array:2 [ "nombre" => "Laura" "apellidos" => "Martín Pedraz" ] 1 => array:2 [ "nombre" => "Rocío" "apellidos" => "Galindo Zavala" ] 2 => array:2 [ "nombre" => "Francisco" "apellidos" => "Nieto Vega" ] 3 => array:2 [ "nombre" => "Irene" "apellidos" => "Sánchez Bazán" ] 4 => array:2 [ "nombre" => "Esmeralda" "apellidos" => "Núñez Cuadros" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S1699258X20301972" "doi" => "10.1016/j.reuma.2020.07.013" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X20301972?idApp=UINPBA00004M" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574321000745?idApp=UINPBA00004M" "url" => "/21735743/0000001800000001/v1_202201261003/S2173574321000745/v1_202201261003/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S2173574321000630" "issn" => "21735743" "doi" => "10.1016/j.reumae.2020.07.008" "estado" => "S300" "fechaPublicacion" => "2022-01-01" "aid" => "1459" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Reumatol Clin. 2022;18:42-8" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "Original Article" "titulo" => "Pregnancy and systemic lupus erythematosus in Spain: Has anything changed in the 21st century?" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "42" "paginaFinal" => "48" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Embarazo y lupus eritematoso sistémico en España: ¿ha cambiado algo en el siglo xxi?" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:2 [ 0 => array:1 [ "imagen" => "gr1a.jpeg" ] 1 => array:1 [ "imagen" => "gr1b.jpeg" ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0005" "detalle" => "Fig. " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "Clinical and serological evolution of the SLE in pregnant patients and during postpartum period. (A) Evolution of the mean values of SLEDAI/SLEPDAI from the visit prior to pregnancy up until the postpartum period; (B) the percentage of patients with serology is shown (anti-DNA + and reduce complement) changed during the same period. Post P: postpartum visit; Pre E: pre-conception visitor r visit prior to pregnancy." ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Manuel de la Hera Madrazo, Pedro Muñoz Cacho, Leyre Riancho Zarrabeitia, Lorena Álvarez Rodríguez, Ana Haya, Marcos López-Hoyos, Víctor M. Martínez-Taboada" "autores" => array:7 [ 0 => array:2 [ "nombre" => "Manuel" "apellidos" => "de la Hera Madrazo" ] 1 => array:2 [ "nombre" => "Pedro" "apellidos" => "Muñoz Cacho" ] 2 => array:2 [ "nombre" => "Leyre" "apellidos" => "Riancho Zarrabeitia" ] 3 => array:2 [ "nombre" => "Lorena" "apellidos" => "Álvarez Rodríguez" ] 4 => array:2 [ "nombre" => "Ana" "apellidos" => "Haya" ] 5 => array:2 [ "nombre" => "Marcos" "apellidos" => "López-Hoyos" ] 6 => array:2 [ "nombre" => "Víctor M." "apellidos" => "Martínez-Taboada" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S1699258X20301935" "doi" => "10.1016/j.reuma.2020.07.009" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X20301935?idApp=UINPBA00004M" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574321000630?idApp=UINPBA00004M" "url" => "/21735743/0000001800000001/v1_202201261003/S2173574321000630/v1_202201261003/en/main.assets" ] "en" => array:20 [ "idiomaDefecto" => true "cabecera" => "Review Article" "titulo" => "Expanded Mesenchymal Stromal Cells in knee osteoarthritis: A systematic literature review" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "49" "paginaFinal" => "55" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Paloma Álvarez Hernández, José de la Mata Llord" "autores" => array:2 [ 0 => array:2 [ "nombre" => "Paloma" "apellidos" => "Álvarez Hernández" ] 1 => array:4 [ "nombre" => "José" "apellidos" => "de la Mata Llord" "email" => array:1 [ 0 => "drdelamata@institutoari.com" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "*" "identificador" => "cor0005" ] ] ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Instituto de Salud Osteoarticular ARI, Madrid, Spain" "identificador" => "aff0005" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Tratamiento de la artrosis de rodilla con células mesenquimales estromales expandidas: revisión sistemática de la literatura" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 2256 "Ancho" => 2167 "Tamanyo" => 231245 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0005" "detalle" => "Fig. " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "Flow diagram." ] ] ] "textoCompleto" => "IntroductionAdvanced cellular therapies are one of the most cutting edge fields in the treatment of osteoarthritis. These are seemingly safe treatments which prospectively fulfil the dual notion of modifying symptom and structure. The greatest protagonist stems from the adult progenitor cells, since they have greater biologic plasticity than the differentiated adult cells (chondrocytes) and are safer than the embryonic progenitor cells. Mesenchymal Stromal Cells [MSCs] are adult progenitor cells derived from the embryonic mesoderm with a marked capacity for self-renewal and depending on the microenvironment in which they are found, adult cells of different mesenchymal lineages may be differentiated (chondrocyte, osteoblast, aipocyte, myocyte and tenocyte).<a class="elsevierStyleCrossRef" href="#bib0005">1</a> This double condition (self-renewal and differentiation) makes them extraordinarily attractive for regenerative strategies of mesenchymal tissues, such as cartilage or bone.<a class="elsevierStyleCrossRef" href="#bib0010">2</a> In animal models of osteoarthritis, MSCs have reproducibly shown their marked ability to repair chondral damage, detain progression and improve symptoms.<a class="elsevierStyleCrossRef" href="#bib0015">3</a> However, clinical experiences with MSCs have not been able to reproduce these virtues, offering a panorama of mixed, inconsistent results.<a class="elsevierStyleCrossRefs" href="#bib0020">4,5</a> Part of this discrepancy may be explained by the notable terminological confusion surrounding the treatment with stem cells. Rather than a single therapy, this involves several very different cellular treatments.<a class="elsevierStyleCrossRef" href="#bib0030">6</a> The most commonly used in clinical practice are characterized by minimal tissue manipulation, marked cellular heterogeneity, a great wealth of growth factors and, above all, a marginal proportion of MSCs.<a class="elsevierStyleCrossRefs" href="#bib0035">7,8</a> In these treatments, it is highly complex to discriminate the therapeutic role of the MSCs due to the large quantity of therapeutic agents (potentially) involved.In order to determine the efficacy and safety of MSCs in osteoarthritis, we did a systematic review of the literature (SRL) which evaluated the treatment of osteoarthritis knees with intra-articular implants of expanded MSC, without scaffolds or surgical co-treatments.Material and methodsSearch strategyA sensitive search was performed in Medline, Cochrane Library and Embassy (up to February 2018) designed by an expert documentalist (MA), using Mesh and free text terms in English and Spanish (<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>). The aim was to identify relevant publications which could have been overlooked. The electronic search was complemented with a manual search into the references of the selected studies.<elsevierMultimedia ident="tbl0005"></elsevierMultimedia>Study selectionStudy selection was made jointly by 2 reviewers (PA) and (JM) in 2 phases: 1) selection by titles and abstracts; 2) recompilation of the complete text with selected references. The said references were analysed by looking at previously established inclusion criteria: adult patients (N ≥ 10), with moderate-severe osteoarthritis of the knee (grade II-IV Kellgren-Lawrence), treated with at least one intra-articular injection of MSCs (according to the phenotype criteria of the ISCT)<a class="elsevierStyleCrossRef" href="#bib0045">9</a> and with minimum follow-up of 6 months. Exclusively level I studies were considered for inclusion: meta-analyses, systematic reviews of prospective studies, randomised clinical trials with control group (randomised controlled trials ) [RCT]) and with no control group (quasi-experimental clinical trials) [QCT]). The following were excluded: observational studies and intra-articular interventions with cellular populations which did not meet with ISCT criteria. Equally, those trials where treatment was administered together with co-interventions with scaffolds or surgical procedures were excluded.Data collection and assessment of qualityData collection of selected publications was carried out by one of the reviewers (PA) with the use of specific, pre-designed templates. When doubt ensued for inclusion of a study, a second critical reading was made by the second reviewer (JM). The final inclusion was determined by consensus. Final data collected in templates were used for the creation of the final summary of findings table.The quality of the evidence was ranked according to the scale of the Scottish Intercollegiate Guidelines Network (SIGN).<a class="elsevierStyleCrossRef" href="#bib0050">10</a> The SIGN method places particular emphasis on quantitative analysis provided by the SRL and also places importance on the reduction of systematic error or bias.ResultsStudy descriptionThe electronic search identified 252 references (18 duplicates were ruled out). After Reading the title and abstract 222 studies were excluded. Twelve relevant articles were selected for critical reading (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>). Nine met with the inclusion critieria<a class="elsevierStyleCrossRefs" href="#bib0055">11–19</a> and 3 were excluded (2 made with cellular implants which did not meet with ISCT<a class="elsevierStyleCrossRefs" href="#bib0100">20,21</a> criteria and one observational study<a class="elsevierStyleCrossRef" href="#bib0110">22</a>). The body of evidence consisted of 9 clinical trials where 169 patients were treated with MSCs (61.8% women and 38.1% men). All clinical trials were concept tests (Phase I-II), 3 RCT controlled with hyaluronic acid (HA)<a class="elsevierStyleCrossRefs" href="#bib0060">12,14,19</a> and 6 QCT.<a class="elsevierStyleCrossRefs" href="#bib0055">11,13,15–18</a> No clinical efficacy trial (Phase III) met with inclusion criteria. One hundred and fifteen patients were treated with MSCs obtained from bone marrow<a class="elsevierStyleCrossRefs" href="#bib0055">11,12,14,15</a>,<a class="elsevierStyleCrossRefs" href="#bib0085">17,19</a> and 54 with MSCs from adipose tissue.<a class="elsevierStyleCrossRefs" href="#bib0065">13,16,18</a> Two studies used more than one dose of MSCs<a class="elsevierStyleCrossRefs" href="#bib0055">11,18</a> and 2 used allergenic MSCs implants.<a class="elsevierStyleCrossRefs" href="#bib0060">12,19</a> Follow-up times ranged between 6 and 24 months. The quality of the evidence assigned was the lowest of that contemplated in the SIGN scale for clinical trials (SIGN 1−), due to the low sample number of studies and that the majority of trials had no control group (<a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>).<elsevierMultimedia ident="fig0005"></elsevierMultimedia><elsevierMultimedia ident="tbl0010"></elsevierMultimedia>Results of efficacyEfficacy of intra-articular treatment with MSCs was assessed clinically and structurally.Clinical efficacyTwo controlled studies reported significant improvement regarding hyaluronic acid.<a class="elsevierStyleCrossRefs" href="#bib0070">14,19</a> Lamo-Espinosa et al.<a class="elsevierStyleCrossRef" href="#bib0070">14</a> found there was an analgesic improvement (VAS) with all doses used. This improvement was progressive from the third month until the maximum of one year. The WOMAC improvement was only observed in patients treated with high doses and was later (one year) (<a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>). In the other RCT, the magnitude of the analgesic and functional improvement was greater than that of the HA from 6 m onwards and it also reached its maximum at one year.<a class="elsevierStyleCrossRef" href="#bib0095">19</a> The third RCT included was adjusted to the same time curve with a maximum response at one year, but with no significant differences regarding HA.<a class="elsevierStyleCrossRef" href="#bib0060">12</a>All QCT reported clinical improvement with respect to their baseline situation (<a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>). In several studies the analgesic benefit (VAS and WOMAC pain) was observed from 3 months onwards.<a class="elsevierStyleCrossRefs" href="#bib0075">15–17</a> However, the improvement of the other functional measurements (not just analgesic ones) did not occur until 6 months. Like with the RCT, the maximum peak clinical benefit was reported one year after implant. This response was maintained in some patients until 24 months.<a class="elsevierStyleCrossRefs" href="#bib0055">11,13,18</a> In general, the clinical response was more consistent in patients treated with the highest doses.<a class="elsevierStyleCrossRefs" href="#bib0065">13,16,18</a>Structural efficacyThe structural modifying effect of the implant with MSCs was reported in 2 RCT<a class="elsevierStyleCrossRefs" href="#bib0070">14,19</a> and 5 QCT.<a class="elsevierStyleCrossRefs" href="#bib0055">11,13,15,17</a>,<a class="elsevierStyleCrossRef" href="#bib0090">18</a> In the RCT, the structural benefit was significant with regard to the HA from one year onwards. After 12 months of implant, patients with MSCs showed a significant reduction in joint space,<a class="elsevierStyleCrossRef" href="#bib0070">14</a> in the Whole-Organ Magnetic Resonance Imaging Score (WORMS)<a class="elsevierStyleCrossRef" href="#bib0070">14</a> and the low quality cartilage area (PCI)<a class="elsevierStyleCrossRef" href="#bib0095">19</a> (<a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>). This structurally modifying effect was only observed in patients treated with doses ≥40 × 106 MSCs. In the QCT, the structural benefit was shown by a lower narrowing of the medial space,<a class="elsevierStyleCrossRef" href="#bib0065">13</a> a reduction of the area of chondral defects,<a class="elsevierStyleCrossRef" href="#bib0065">13</a> of the T2 map of the collagen composition<a class="elsevierStyleCrossRef" href="#bib0085">17</a> and by an increase in cartilage thickness.<a class="elsevierStyleCrossRefs" href="#bib0055">11,13,18</a> These changes were reported one year after implant although the reduction of the PCI was observed from 6 months onwards.<a class="elsevierStyleCrossRef" href="#bib0075">15</a> Like in the RCT, patients with the most consistent improvements were those who received the highest dose of MSCs (≥40 × 106).<a class="elsevierStyleCrossRefs" href="#bib0065">13,15,17,1</a>Safety resultsSafety data coincided in all studies. Intra-articular injection of MSCs was a well tolerated and safe intervention in all patients. Factors such as dose (high or low number of MSCs), administration regimen (one or more injections), source of MSCs (adipose tissue or bone marrow) and type of transplant (autologous or allergenic) did not alter favourable tolerance. Systemic reactions associated with treatment were not described, and only one case of hospital admission was reported, due to synovial fluid effusion which evolved favourably in 24 h.<a class="elsevierStyleCrossRef" href="#bib0060">12</a> The most common side effect was the appearance of minor local reaction (pain and/or inflammation) in the puncture site (13%–53% of patients) (<a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>). In all cases, symptoms were temporary and treated locally with ice (occasionally with anti-inflammatories) in under 7 days. In the controlled studies, the incidence of these local effects did not present with any significant differences to those observed in patients treated with HA.<a class="elsevierStyleCrossRefs" href="#bib0060">12,14,19</a>DiscussionThe immunomodulator and regenerative potential of MSCs has positioned this type of therapy as one of the most promising in the therapeutic panorama of osteoarthritis. The use of stem cells in regenerative cartilage strategies is a highly appealing but also widely debated subject. This is the first SRL to analyse cellular treatment with quantifiable and phenotypically homogeneous MSCs implants. Our safety results coincide with previous studies<a class="elsevierStyleCrossRefs" href="#bib0020">4,5</a> and confirm that the expanded MSCs implant is a well tolerated and safe intervention, with no systemic toxicity. A significant percentage of patients suffered pain and/or local inflammation but this was temporary, insignificant and very similar to that of other intra-articular treatments. In general, it seems to occur more commonly in those patients treated with higher cellular doses and/or with higher injection volumes.We were unable to reach a conclusion regarding the efficacy of MSCs from the evidence. The 9 concept test studies included, although prospective, were markedly biased by the low sample size, insufficient statistical power and lack of a control group. However, interesting conclusions were providing relating to their foundation and their possible utility in osteoarthritis. In this respect, the implant of MSCs showed a greater (and more sustained) clinical benefit than HA.<a class="elsevierStyleCrossRefs" href="#bib0070">14,19</a> This analgesic-functional improvement required a latency period greater than that observed with HA. Characteristically, analgesic improvement occurs at the beginning which precedes a more complete functional improvement. This early analgesia is a characteristic which has been confirmed by other studies,<a class="elsevierStyleCrossRef" href="#bib0115">23</a> and has been linked to an initial paracrine and anti-inflammatory action of the implant. The potential of the MSCs self-renewal and differentiation would lead months later to the structural improvement observed at one year.<a class="elsevierStyleCrossRef" href="#bib0120">24</a> From our results it may be deduced that the clinical and structural benefit produced by the MSCs may become quite sustained over time (up to 2 years)<a class="elsevierStyleCrossRefs" href="#bib0055">11,13,18</a> Recent studies appear to confirm this virtue, communicating stable clinical and structural improvements up to 4 years after the implant.<a class="elsevierStyleCrossRef" href="#bib0125">25</a> One unanswered question from this review is the ideal cellular dose with which the maximum clinical and structural benefit may be obtained. Approximately, the most complete clinical improvements and the most notable radiologic changes were obtained with equal or higher doses to a 40 × 106 cells. This cut-off point appears to coincide with a range reported in the literature which, in general, inclines towards equal or higher doses.<a class="elsevierStyleCrossRef" href="#bib0130">26</a> However, as occurs in some of the review trials,<a class="elsevierStyleCrossRef" href="#bib0080">16</a> it is viable to say that there is analgesic improvement with a considerably lower doses.<a class="elsevierStyleCrossRef" href="#bib0120">24</a> In view of this observation, it would appear that to obtain a paracrine and anti-inflammatory effect cellular implants do not need to be used in such large quantities.<a class="elsevierStyleCrossRef" href="#bib0135">27</a> Regarding the radiologic benefit, our results confirm previous experiences which report an interesting regenerating effect of chondral damage.<a class="elsevierStyleCrossRef" href="#bib0140">28</a> Singularly, this is governed by a response pattern which is in keeping with the improvement of functional parameters: significant from 6 months onwards and for a maximum of one year. The consistency of this pattern could prove that chondral damage repair is necessary to provide a more complete clinical and improvement which does not appear in the first few months, despite the analgesic benefit.The results of this review should be interpreted with caution due to many limitations. To those already mentioned, such as the small sample size and main absence of a control group, we should add selection biases and poor classification, possibly accounted for by the fact that patients with the most severe osteoarthritis were those finally treated with MSCs. The absence of masking meant it was highly possible then there was the added existence of assessment biases, in which the intervention (treatment with MSCs) was particularly weighed by the assessor. Despite being a well-defined intervention, the great heterogeneity of dose and administration protocols was striking, making it difficult to compare different treatments. This heterogeneity is also applicable to the parameters which assessed radiologic damage. The huge variability of measures chosen and the low sample seize impeded the drawing of consistent conclusions regarding the magnitude of the benefit or the determination of a dose-response pattern.To sum up, this review proposes a basis for the therapeutic use of expanded MSCs in osteoarthritis as a modifying treatment of symptoms and structure. Its efficacy in clinical trials has been confirmed and it is a safe technique for patients, and is viable for rheumatologists. However, to become a real and accessible alternative, MSCs implants must also overcome other logistic and financial barriers. In this sense the good safety results of the allergenic implants in the review, validate previous experiences.<a class="elsevierStyleCrossRef" href="#bib0145">29</a> They provide interesting clinical information in favour of the bio bank implants, at a lower cost, without discomfort for the patient and with higher logistic advantages. Among these is access to MSCs from the umbilical cord which are widely available and also (potentially) effective in osteoarthritis of the knee.<a class="elsevierStyleCrossRefs" href="#bib0150">30,31</a> We will have to wait for the results of ongoing clinical trials to confirm whether this preliminary promising evidence materialises as consistent and reproducible benefits.Conflict of interestsThe authors have no conflict of interests to declare." "textoCompletoSecciones" => array:1 [ "secciones" => array:10 [ 0 => array:3 [ "identificador" => "xres1655532" "titulo" => "Abstract" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0005" "titulo" => "Objective" ] 1 => array:2 [ "identificador" => "abst0010" "titulo" => "Methods" ] 2 => array:2 [ "identificador" => "abst0015" "titulo" => "Results" ] 3 => array:2 [ "identificador" => "abst0020" "titulo" => "Conclusions" ] ] ] 1 => array:2 [ "identificador" => "xpalclavsec1471557" "titulo" => "Keywords" ] 2 => array:3 [ "identificador" => "xres1655533" "titulo" => "Resumen" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0025" "titulo" => "Objetivo" ] 1 => array:2 [ "identificador" => "abst0030" "titulo" => "Métodos" ] 2 => array:2 [ "identificador" => "abst0035" "titulo" => "Resultados" ] 3 => array:2 [ "identificador" => "abst0040" "titulo" => "Conclusiones" ] ] ] 3 => array:2 [ "identificador" => "xpalclavsec1471556" "titulo" => "Palabras clave" ] 4 => array:2 [ "identificador" => "sec0005" "titulo" => "Introduction" ] 5 => array:3 [ "identificador" => "sec0010" "titulo" => "Material and methods" "secciones" => array:3 [ 0 => array:2 [ "identificador" => "sec0015" "titulo" => "Search strategy" ] 1 => array:2 [ "identificador" => "sec0020" "titulo" => "Study selection" ] 2 => array:2 [ "identificador" => "sec0025" "titulo" => "Data collection and assessment of quality" ] ] ] 6 => array:3 [ "identificador" => "sec0030" "titulo" => "Results" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "sec0035" "titulo" => "Study description" ] 1 => array:3 [ "identificador" => "sec0040" "titulo" => "Results of efficacy" "secciones" => array:1 [ 0 => array:2 [ "identificador" => "sec0045" "titulo" => "Clinical efficacy" ] ] ] 2 => array:2 [ "identificador" => "sec0050" "titulo" => "Structural efficacy" ] 3 => array:2 [ "identificador" => "sec0055" "titulo" => "Safety results" ] ] ] 7 => array:2 [ "identificador" => "sec0060" "titulo" => "Discussion" ] 8 => array:2 [ "identificador" => "sec0065" "titulo" => "Conflict of interests" ] 9 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2020-07-13" "fechaAceptado" => "2020-10-15" "PalabrasClave" => array:2 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec1471557" "palabras" => array:4 [ 0 => "Mesenchymal Stromal Cells" 1 => "Knee osteoarthritis" 2 => "Intra-articular treatment" 3 => "Systematic literature review" ] ] ] "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec1471556" "palabras" => array:5 [ 0 => "Células mesenquimales estromales" 1 => "Células madre" 2 => "Artrosis de rodilla" 3 => "Tratamiento intra-articular" 4 => "Revisión sistemática" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:3 [ "titulo" => "Abstract" "resumen" => "ObjectiveTo analyse the efficacy and safety of intra-articular injection of expanded Mesenchymal Stromal Cells (MSCs) in knee osteoarthritis. MethodsSystematic Literature Review. A pre-defined search strategy was run in Medline, Embase and Cochrane Library until February 2018. Inclusion criteria: knee osteoarthritis (grades II-IV Kellgren-Lawrence); intra-articular injection of MSCs (without surgical co-treatments); Randomized Controlled Trials (RCTs) or Quasi-experimental Clinical Trials (QCTs) N ≥ 10 and ≥6 months of follow-up were included. Evidence was assigned according to the Scottish Intercollegiate Guidelines Network (SIGN). ResultsThe search identified 252 articles. Nine proof-of-concept trials (3 RCTs, 6 QCTs) were included (N = 169). Evidence showed clinical improvement in 60% of patients. Structural benefit was reported in half of patients. Clinical benefit was observed from the 3rd month and structural improvement from the 6th. All studies reported maximum clinical and structural benefit a year following the implant. This benefit was sustained for up to 24 months. Studies with doses ≥40 × 106 showed more consistent clinical and structural benefits than those with lower doses. No systemic adverse reactions were reported. The most common adverse effect was pain and/or inflammation in the puncture area (13–53%). The use of donor cells was as safe as autologous implants. ConclusionsIntra-articular implants of MSCs seem to be safe with no serious adverse effects. Low-quality evidence precludes conclusions regarding efficacy in this review. However, the clinical and structural benefits observed provide a rationale for using expanded MSCs implants in osteoarthritis patients. High-quality evidence trials are needed to further determine best protocols to maximize clinical and structural improvement." "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0005" "titulo" => "Objective" ] 1 => array:2 [ "identificador" => "abst0010" "titulo" => "Methods" ] 2 => array:2 [ "identificador" => "abst0015" "titulo" => "Results" ] 3 => array:2 [ "identificador" => "abst0020" "titulo" => "Conclusions" ] ] ] "es" => array:3 [ "titulo" => "Resumen" "resumen" => "ObjetivoAnalizar la eficacia y la seguridad de los implantes de células mesenquimales estromales expandidas (MSCs, por sus siglas en inglés) en la artrosis de rodilla. MétodosRevisión sistemática de la literatura. Estrategia de búsqueda en Medline, Embase y Cochrane Library hasta febrero del 2018. Inclusión: artrosis de rodilla (II-IV Kellgren); inyección intra-articular de MSCs; ensayos controlados aleatorizados (ECA) y ensayos clínicos cuasi-experimentales (ECC) ≥ 6 meses y N ≥ 10. ResultadosDe 252 artículos identificados, se incluyeron 3 ECA y 6 ECC (N = 169). El 60% de los pacientes mejoraron clínicamente y el 50% estructuralmente hasta 2 años después del implante. El beneficio máximo se alcanzó al año con dosis ≥40 × 106 MSCs. La intervención fue bien tolerada, igualmente segura en implantes alogénicos y autólogos. ConclusionesLas MSCs intra-articulares son seguras. La baja calidad de la evidencia analizada no admite conclusiones sobre la eficacia, pero prueba un fundamento para su uso en la artrosis como modificador de síntoma y de estructura que debe ser constatado en ensayos de alta calidad." "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0025" "titulo" => "Objetivo" ] 1 => array:2 [ "identificador" => "abst0030" "titulo" => "Métodos" ] 2 => array:2 [ "identificador" => "abst0035" "titulo" => "Resultados" ] 3 => array:2 [ "identificador" => "abst0040" "titulo" => "Conclusiones" ] ] ] ] "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "Please cite this article as: Álvarez Hernández P, de la Mata Llord J. Tratamiento de la artrosis de rodilla con células mesenquimales estromales expandidas: revisión sistemática de la literatura. Reumatol Clin. 2022;18:49–55." ] ] "multimedia" => array:3 [ 0 => array:8 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 2256 "Ancho" => 2167 "Tamanyo" => 231245 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0005" "detalle" => "Fig. " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "Flow diagram." ] ] 1 => array:8 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0010" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Pubmed Results of the search: 168 \t\t\t\t\t\t\n \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">(“Osteoarthritis, Knee”[Mesh]) AND (((((((((((“Stromal Cells”[Mesh]) OR “Multipotent Stem Cells”[Mesh]) OR “Mesenchymal Stromal Cells”[Mesh]) OR “Stem Cells”[Mesh]) OR “Fetal Stem Cells”[Mesh]) OR “Pluripotent Stem Cells”[Mesh]) OR “Embryonic Stem Cells”[Mesh]) OR “Induced Pluripotent Stem Cells”[Mesh])) OR ((“Stromal Cells”[Title/Abstract] OR “Multipotent Stem Cells”[Title/Abstract] OR “Mesenchymal Cells”[Title/Abstract] OR “stem cell”[Title/Abstract] OR “embryonic”[Title/Abstract] OR “Induced Pluripotent Stem Cells” OR))) OR ((“Progenitor Cell* Mesenchymal”[Title/Abstract] OR “Mother Cell*”[Title/Abstract] OR “Colony-Forming Unit*”[Title/Abstract] OR “IPS Cell*”[Title/Abstract]))). \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Filters: Spanish, English, humans. \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Embase Results of the search: 25 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">(knee NEAR/3 osteoarthritis) AND ((‘stromal cell’/de OR 'multipotent stem cell'/de OR 'stem cell'/de OR 'fetal stem cell'/de OR 'pluripotent stem cell'/de OR 'embryonic stem cell'/de OR 'induced pluripotent stem cell') OR ('progenitor cell mesenchymal’ OR 'mother cell' OR 'colony forming unit')) AND [embase]/lim NOT ([embase]/lim AND [medline]/lim) AND ([English]/lima OR [Spanish]/lim) AND [humans]/lim. \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Filers: Spanish, English, humans. \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Cochrane Results of the search: 59 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">[mh “Osteoarthritis Knee”] OR (knee near/3 osteoarthritis) AND ([mh “Stromal Cells”] or [mh “Multipotent Stem Cells”] or [mh “Mesenchymal Stromal Cells”] or [mh “Stem Cells”] or [mh “Fetal Stem Cells”] or [mh “Pluripotent Stem Cells”] or [mh “Embryonic Stem Cells”] or [mh “Induced Pluripotent Stem Cells”] OR (“Stromal Cells” or “Multipotent Stem Cells” or “Mesenchymal Cells” or “stem cell” or “embryonic” or “Induced Pluripotent Stem Cells”) OR ('stromal cells' or 'multipotent stem cells' or 'mesenchymal cells' or 'stem cell' or 'embryonic' or 'induced pluripotent stem cells') OR ('progenitor cell mesenchymal' or 'mother cell' or 'colony forming unit')). \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Filters: Spanish, English, humans. \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab2818055.png" ] ] ] ] "descripcion" => array:1 [ "en" => "Search strategy." ] ] 2 => array:8 [ "identificador" => "tbl0010" "etiqueta" => "Table 2" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0015" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:2 [ "leyenda" => "AT: adipose tissue; BB: blood biochemistry; BM: bone marrow; BMI: body mass index; EKG: electrocardiogram; HA: hyaluronic acid; HAQ: Health Assessment Questionnaire; ICOAP: Intermittent & Constant Osteoarthritis pain score; KOOS: Knee injury and Osteoarthritis Outcome Score; KSS: Knee Society clinical rating system; KX: knee X-ray; NMR: nuclear magnetic resonance; NSAID: non steroid anti inflammatory drugs; PE: physical examination; PCI: poor cartilage index; PGA: Patient Global Assessment; Pl: placebo; QCT: quasi-experimental clinical trials; RCT: random controlled trials; SAS: Short Arthritis Assessment Scale; SF-36: Short Form questionnaire; SIGN: Scottish Intercollegiate Guidelines Network; VSF: vascular stromal fraction; VAS: Visual Analogue Scale; ESR: erythrocyte sedimentation rate; W: week; WOMAC: Western Ontario & McMaster Universities Osteoarthritis Index; WORMS: Whole-Organ Magnetic Resonance Imaging Score." "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Author, year of publication (reference) \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Type of study and follow-up \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Population (number, percentage of women, mean age, eligibility) \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Intervention \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Measurements of outcome \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Results \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">SIGN Quality \t\t\t\t\t\t\n \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Gupta et al., 2016<a class="elsevierStyleCrossRef" href="#bib0060">12</a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">RCT 12 m \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">N = 6050%56 ± 6 yearsKellgren II-III; pain which requires NSAID \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">allogenic BM MSCs (Stempeucel©)25 × 106 (2 ml) + HA n = 10; Pl + HA n = 550 × 106 (2 ml) + HA n = 10; Pl + HA n = 575 × 106 (4 ml) + HA n = 10; Pl + HA n = 5150 × 106 (4 ml) + HA n = 10; Pl + HA n = 5HA = Hyalgan® 2 ml \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Safety: PE, EKG, haemogram, ESR, BB at 1, 12, 24 and 48 wEfficacy: VAS, WOMAC, ICOAP at 1, 12, 24 and 48 wStructural NMR (0, 24 and 48 w); KX (0, 12, 24 w) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Safety: safe at 12 m. 16% post-puncture discomfort. One hospitalisation due to synovial fluid Efficacy: No improvement Structural No improvement \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Quality 1−Comments: low sample in asymmetrical groups. Low discriminatory power. Short follow-up for structural efficacy; heterogeneous intervention \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Lamo-Espinosa et al., 2016<a class="elsevierStyleCrossRef" href="#bib0070">14</a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">RCT 12 m \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">N = 3037%61,3 ± 5 yearsKellgren II-IV; VAS ≥ 2,5; BMI 20-35 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Autologous BM MSCs Low dose: 10 × 106 (1,5 ml) + HA n = 10High dose: 150 × 106 (3,5 ml) + HA n = 10Control: HA n = 10HA = Hyalone® 4 ml \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Safety: PE, haemogram, BBEfficacy: VAS, WOMAC 0, 3, 6, 12 m“WOMAC responders” = ↓20% 2 items and >↓10 points of total scale Structural NMR and KX (0, 6 and 12 m) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Safety: safe at 12 m. 13% post-puncture discomfortEfficacy: ↓ VAS from 3 m, maximum 12 m. No differences between groups; “WOMAC responders” with High doses at 12 mStructural improvement at 12 months only in high doses (4 WORMS points) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Quality 1−Comments: low sample; no masking; heterogeneous groups; low discriminatory power. Short follow-up for structural efficacy \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Vega et al., 2015<a class="elsevierStyleCrossRef" href="#bib0095">19</a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">RCT 12 m \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">N = 3057%57 ± 9 yearsKellgren II-IV; Chronic refractory pain ≥ 6 m \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Allogenic BM MSCs MSCs: 40 × 106 (1,5 ml) n = 15Control: HA (Durolane® 3 ml) n = 15Source MSCs: 3 healthy donors from the sample \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Safety: PE, haemogram, BBEfficacy: VAS, WOMAC, Lequesme (0, 3, 6, 12 m)Structural NMR (0, 6 and 12 m) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Safety: safe at 12 m. 53% post-puncture discomfortClinical Efficacy: significant improvement with VAS, WOMAC, Lequesme from 6 mStructural improvement at 12 months of PCI \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Quality 1−Comments: low sample; no masking; low discriminatory power. Short follow-up for structural efficacy \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Jo et al., 2017<a class="elsevierStyleCrossRef" href="#bib0065">13</a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">QCT 6 m \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">N = 1883%61 ± 6 yearsKellgren III-IV; VAS 4 ≥ 4 m \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Autologous AT MSCs Low dose: 10 × 106 (3 ml) (n = 3)Medium dose: 50 × 106 (3 ml) (n = 3)High dose: 100 × 106 (3 ml) (n = 12) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Safety: PE, haemogram, BBEfficacy: VAS, WOMAC, KSS, KOOS 0, 1, 2, 3, 6, 12, 24 mStructural NMR (3, 6 and 24 m) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Safety: safe at 24 mClinical Efficacy: significant improvement only with high doses: VAS, WOMAC, KOOS and KSS (maximum at 12 m)Structural improvement with High doses at 6 m of interline, ↓ chondral defects and ↑ cartilage column. Then plateau \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Quality 1−Comments: low sample; lost data; no control; safety data incomplete; arthroscopy bias \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Pers et al., 2016<a class="elsevierStyleCrossRef" href="#bib0080">16</a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">QCT 6 m \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">N = 1856%64 ± 8 yearsKellgren III-IV; Chronic pain ≥ 12 m \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Autologous AT MSCs (from VSF)Low dose: 2 × 106 (5 ml) (n = 6)Medium dose: 10 × 106 (5 ml) (n = 6)High dose: 50 × 106 (5 ml) (n = 6) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Safety: PE, haemogram, BB.Efficacy: VAS, WOMAC, PGA, SAS, SF-36, KOOS 0, 1 s, 3 m, 6 m“Responder” = ↓20% VAS and WOMACStructural NMR (0, 4 m) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Safety: safe 22% post-puncture discomfortClinical efficacy: Significant improvement from 1.ª only with Low doses: VAS, WOMAC, KOOS and responders (maximum at 3 m)Structural improvement inconclusive \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Quality 1−Comments: low sample; lost data; no control; heterogeneous groups; NMR results incomplete \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Song et al., 2016<a class="elsevierStyleCrossRef" href="#bib0090">18</a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">QCT 24 m \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">N = 1878%55 ± 10 yearsKellgren II-III; VAS ≥ 4 > 4 m \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Autologous AT MSCs PHASE I (2 doses separated by 3 w)Low dose: 10 × 106 (3 ml) (n = 6)Medium dose: 20 × 106 (3 ml) (n = 6)High dose: 50 × 106 (3 ml) (n = 6)PHASE IIa (additional dose 50 × 106 after one year) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Safety: PE, EKG, haemogram, ESR, BB every 2 s × 12 mEfficacy: WOMAC, NRS-11, SF-36 (0, 12, 24, 48, 72, 96 w)Structural NMR (0, 12, 24, 48, 72, 96 w) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Safety: safe 44% post-puncture discomfortClinical efficacy: consistent only with high doses. NRS-11 improvement from 3-24 m; WOMAC from 6 to 12 m, then plateauStructural increase thickness of cartilage greater with high doses \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Quality 1−Comments: potential multi-dose benefit; low sample; no control; results biased for a efficacy; heterogeneous groups; confusing methodology \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Al-Najar et al., 2017<a class="elsevierStyleCrossRef" href="#bib0055">11</a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">QCT 24 m \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">N = 1378%50 ± 10 yearsKellgren II-III; Chronic pain ≥ 6 m \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Autologous AT MSCs Two doses 30.5 × 106 (5 ml) separated by 4 w \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Safety: PE (1, 2, 4, 12 s and then every 6 m), haemogram and BB (3, 24 m)Efficacy: KOOS (1, 2, 4, 6, 12, 24 m)Structural NMR (6, 12 m) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Safety: safe 23% post-puncture discomfortClinical efficacy: improvement KOSS from 6 to 12 m, then plateauStructural increase of cartilage thickness at 12 m \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Quality 1−Comments: very low sample and biased for efficacy; no control group \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Orozco et al., 2013<a class="elsevierStyleCrossRef" href="#bib0075">15</a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">QCT 12 m \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">N = 1250%49 ± 5 yearsKellgren II-IV; Refractory pain ≥ 6 m \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Autologous BM MSCs Single dose 40 × 106 (8 ml) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Safety: PE, haemogram, BB (1 s, 3, 6, 12 m)Efficacy: VAS (0, 3, 6, 12 m), WOMAC and Lequesme (0 y 12 m)Structural NMR (. 6 and 12 m) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Safety: safe at 12 m. 50% post-puncture discomfortClinical efficacy: significant VAS improvement from 3 m, maximum at 12 m. Improvement WOMAC, Lequesme at 12 mStructural improvement at 6 and 12 m of PCI \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Quality 1−Comments: improvement and safety maintained in follow-up at 24 m.Very low sample and biased for efficacy; no control \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Soler et al., 2015<a class="elsevierStyleCrossRef" href="#bib0085">17</a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">QCT 12 m \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">N = 1560%52 ± 5 yearsKellgren II-III; Chronic mechanical pain \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Autologous BM MSCs Single dose: 40.9 × 106 ± .4 × 106 (10.0 ± .3 ml) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Safety: PE, haemogram, BB (1 w, 3, 6, 12 m)Efficacy: VAS (0, 3, 6, 12 m), HAQ pain, SF-36, WOMAC and Lequesme (0, 6 and 12 m)Structural NMR, T2 mapping of composition of collagen of the cartilaginous matrix (. 6 and 12 m) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Safety: safe at 12 m. 60% post-puncture discomfort. Lumbago 27%Clinical efficacy: significant VAS improvement from 8 d, maximum to 12 m. Improvement WOMAC, Lequesme at 12 m. No improvement SF-36Structural significant reduction of T2 map at 12 months \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Quality 1−Comments: improvement and safety maintained at 4 years. Better in patient candidates with moderate osteoarthritis. Very low sample and biased for efficacy; no control group \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab2818054.png" ] ] ] ] "descripcion" => array:1 [ "en" => "Summary of evidence" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:31 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Mesenchymal stem cell-based therapy of osteoarthritis: current knowledge and future perspectives" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "C.R. Harrell" 1 => "B.S. Markovic" 2 => "C. Fellabaum" 3 => "A. Arsenijevic" 4 => "V. Volarevic" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.biopha.2018.11.099" "Revista" => array:7 [ "tituloSerie" => "Biomed Pharmacother." "fecha" => "2019" "volumen" => "109" "paginaInicial" => "2318" "paginaFinal" => "2326" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30551490" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S0140673620301835" "estado" => "S300" "issn" => "01406736" ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Mesenchymal stem cell and regenerative medicine: regeneration versus immunomodulatory challenges" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "S. Law" 1 => "S. Chaudhuri" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Am J Stem Cells." "fecha" => "2013" "volumen" => "2" "paginaInicial" => "22" "paginaFinal" => "38" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23671814" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Direct transplantation of mesenchymal stem cells into the knee joints of Hartley strain guinea pigs with spontaneous osteoarthritis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Sato" 1 => "K. Uchida" 2 => "H. Nakajima" 3 => "T. Miyazaki" 4 => "A.R. Guerrero" 5 => "S. Watanabe" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/ar3735" "Revista" => array:5 [ "tituloSerie" => "Arthritis Res Ther." "fecha" => "2012" "volumen" => "14" "paginaInicial" => "R31" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22314040" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Stem cell injections in knee osteoarthritis: a systematic review of the literature" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "H.I. Pas" 1 => "M. Winters" 2 => "H.J. Haisma" 3 => "M.J. Koenis" 4 => "J.L. Tol" 5 => "M.H. Moen" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1136/bjsports-2016-096793" "Revista" => array:6 [ "tituloSerie" => "Br J Sports Med." "fecha" => "2017" "volumen" => "51" "paginaInicial" => "1125" "paginaFinal" => "1133" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28258177" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Efficacy of mesenchymal stem cells injection for the management of knee osteoarthritis: a systematic review and meta-analysis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "P. Xia" 1 => "X. Wang" 2 => "Q. Lin" 3 => "X. Li" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00264-015-2785-8" "Revista" => array:6 [ "tituloSerie" => "Int Orthop." "fecha" => "2015" "volumen" => "39" "paginaInicial" => "2363" "paginaFinal" => "2372" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25944079" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0030" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Nomenclature inconsistency and selective outcome reporting hinder understanding of stem cell therapy for the knee" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "I.A. Jones" 1 => "X. Chen" 2 => "D. Evseenko" 3 => "C.T. Vangsness Jr" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2106/JBJS.17.01474" "Revista" => array:6 [ "tituloSerie" => "J Bone Joint Surg Am." "fecha" => "2019" "volumen" => "101" "paginaInicial" => "186" "paginaFinal" => "195" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30653050" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0035" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Adipose stem cells: biology and clinical applications for tissue repair and regeneration" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "L.E. Kokai" 1 => "K. Marra" 2 => "J.P. Rubin" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.trsl.2013.11.009" "Revista" => array:6 [ "tituloSerie" => "Transl Res." "fecha" => "2014" "volumen" => "163" "paginaInicial" => "399" "paginaFinal" => "408" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24361334" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0040" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "S. Kern" 1 => "H Eichler" 2 => "J Stoeve" 3 => "H. Klüter" 4 => "K. Bieback" ] ] ] ] ] "host" => array:2 [ 0 => array:2 [ "doi" => "10.1634/stemcells.2005-0342" "Revista" => array:6 [ "tituloSerie" => "Stem Cells." "fecha" => "2006" "volumen" => "24" "paginaInicial" => "1294" "paginaFinal" => "1301" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16410387" "web" => "Medline" ] ] ] ] 1 => array:2 [ "doi" => "10.1634/stemcells.2005-0342" "WWW" => array:1 [ "link" => "https://doi.org/10.1634/stemcells.2005-0342" ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0045" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Dominici" 1 => "K. Le Blanc" 2 => "I. Mueller" 3 => "I. Slaper-Cortenbach" 4 => "F. Marini" 5 => "D. Krause" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1080/14653240600855905" "Revista" => array:6 [ "tituloSerie" => "Cytotherapy." "fecha" => "2006" "volumen" => "8" "paginaInicial" => "315" "paginaFinal" => "317" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16923606" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0050" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Forming guideline recommendations. SIGN 50" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "Network SIG" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Libro" => array:1 [ "fecha" => "2008" ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0055" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Intra-articular injection of expanded autologous bone marrow mesenchymal cells in moderate and severe knee osteoarthritis is safe: a phase I/II study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Al-Najar" 1 => "H. Khalil" 2 => "J. Al-Ajlouni" 3 => "E. Al-Antary" 4 => "M. Hamdan" 5 => "R. Rahmeh" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/s13018-017-0689-6" "Revista" => array:5 [ "tituloSerie" => "J Orthop Surg Res." "fecha" => "2017" "volumen" => "12" "paginaInicial" => "190" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29233163" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0060" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Efficacy and safety of adult human bone marrow-derived, cultured, pooled, allogeneic mesenchymal stromal cells (Stempeucel®): preclinical and clinical trial in osteoarthritis of the knee joint" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "P.K. Gupta" 1 => "A. Chullikana" 2 => "M. Rengasamy" 3 => "N. Shetty" 4 => "V. Pandey" 5 => "V. Agarwal" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/s13075-016-1195-7" "Revista" => array:6 [ "tituloSerie" => "Arthritis Res Ther." "fecha" => "2016" "volumen" => "18" "paginaInicial" => "301" "paginaFinal" => "319" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27993154" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0065" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Intra-articular injection of mesenchymal stem cells for the treatment of osteoarthritis of the knee: a proof-of-concept clinical trial" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "C.H. Jo" 1 => "Y.G. Lee" 2 => "W.H. Shin" 3 => "H. Kim" 4 => "J.W. Chai" 5 => "E.C. Jeong" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/stem.1634" "Revista" => array:6 [ "tituloSerie" => "Stem Cells." "fecha" => "2014" "volumen" => "32" "paginaInicial" => "1254" "paginaFinal" => "1266" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24449146" "web" => "Medline" ] ] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0070" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Intra-articular injection of two different doses of autologous bone marrow mesenchymal stem cells versus hyaluronic acid in the treatment of knee osteoarthritis: multicenter randomized controlled clinical trial (phase I/II)" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J. Lamo-Espinosa" 1 => "G. Mora" 2 => "J. Blanco" 3 => "F. Granero-Moltó" 4 => "J. Nuñez-Córdoba" 5 => "C. Sánchez-Echenique" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/s12967-016-0998-2" "Revista" => array:6 [ "tituloSerie" => "J Transl Med." "fecha" => "2016" "volumen" => "14" "paginaInicial" => "246" "paginaFinal" => "255" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27565858" "web" => "Medline" ] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0075" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Treatment of knee osteoarthritis with autologous mesenchymal stem cells: a pilot study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "L. Orozco" 1 => "A. Munar" 2 => "R. Soler" 3 => "M. Alberca" 4 => "F. Soler" 5 => "M. Huguet" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/TP.0b013e318291a2da" "Revista" => array:6 [ "tituloSerie" => "Transplantation." "fecha" => "2013" "volumen" => "95" "paginaInicial" => "1535" "paginaFinal" => "1541" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23680930" "web" => "Medline" ] ] ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0080" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Adipose mesenchymal stromal cell-based therapy for severe osteoarthritis of the knee: a phase I dose-escalation trial" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "Y.M. Pers" 1 => "L. Rackwitz" 2 => "R. Ferreira" 3 => "O. Pullig" 4 => "C. Delfour" 5 => "F. Barry" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.5966/sctm.2015-0245" "Revista" => array:6 [ "tituloSerie" => "Stem Cells Transl Med." "fecha" => "2016" "volumen" => "5" "paginaInicial" => "847" "paginaFinal" => "856" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27217345" "web" => "Medline" ] ] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib0085" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Final results of a phase I-II trial using ex vivo expanded autologous mesenchymal stromal cells for the treatment of osteoarthritis of the knee confirming safety and suggesting cartilage regeneration" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "R. Soler" 1 => "L. Orozco" 2 => "A. Munar" 3 => "M. Huguet" 4 => "R. Lopez" 5 => "J. Vives" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.knee.2015.08.013" "Revista" => array:6 [ "tituloSerie" => "Knee." "fecha" => "2016" "volumen" => "23" "paginaInicial" => "647" "paginaFinal" => "654" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26783191" "web" => "Medline" ] ] ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib0090" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Human adipose-derived mesenchymal stem cells for osteoarthritis: a pilot study with long-term follow-up and repeated injections" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "Y. Song" 1 => "H. Du" 2 => "C. Dai" 3 => "L. Zhang" 4 => "S. Li" 5 => "D.J. Hunter" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2217/rme-017-0152" "Revista" => array:6 [ "tituloSerie" => "Regen Med." "fecha" => "2018" "volumen" => "13" "paginaInicial" => "295" "paginaFinal" => "307" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29417902" "web" => "Medline" ] ] ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib0095" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Treatment of knee osteoarthritis with allogeneic bone marrow mesenchymal stem cells: a randomized controlled trial" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A. Vega" 1 => "M.A. Martin-Ferrero" 2 => "F. del Canto" 3 => "M. Alberca" 4 => "V. Garcia" 5 => "A. Munar" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/TP.0000000000000678" "Revista" => array:6 [ "tituloSerie" => "Transplantation." "fecha" => "2015" "volumen" => "99" "paginaInicial" => "1681" "paginaFinal" => "1690" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25822648" "web" => "Medline" ] ] ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib0100" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The effect of intra-articular injection of autologous bone marrow stem cells on pain and knee function in patients with osteoarthritis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "D. Garay-Mendoza" 1 => "L. Villarreal-Martínez" 2 => "A. Garza-Bedolla" 3 => "D.M. Pérez-Garza" 4 => "C. Acosta-Olivo" 5 => "F. Vilchez-Cavazos" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/756-185X.13139" "Revista" => array:6 [ "tituloSerie" => "Int J Rheum Dis." "fecha" => "2018" "volumen" => "21" "paginaInicial" => "140" "paginaFinal" => "147" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28752679" "web" => "Medline" ] ] ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib0105" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A prospective, single-blind, placebo-controlled trial of bone marrow aspirate concentrate for knee osteoarthritis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "S.A. Shapiro" 1 => "S.E. Kazmerchak" 2 => "M.G. Heckman" 3 => "A.C. Zubair" 4 => "MI O’Connor" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/0363546516662455" "Revista" => array:6 [ "tituloSerie" => "Am J Sports Med." "fecha" => "2017" "volumen" => "45" "paginaInicial" => "82" "paginaFinal" => "90" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27566242" "web" => "Medline" ] ] ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib0110" "etiqueta" => "22" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Treatment of knee osteoarthritis with autologous expanded bone marrow mesenchymal stem cells: 50 cases clinical and MRI results at one year follow-up" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "R.M. Soler Rich" 1 => "A. Soler Romagosa" 2 => "F. Peirau" 3 => "X. Huguet" 4 => "M. Alberca" 5 => "M. Sánchez" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.4172/2157-7633.1000285" "Revista" => array:5 [ "tituloSerie" => "J Stem Cell Res Ther." "fecha" => "2015" "volumen" => "5" "paginaInicial" => "285" "paginaFinal" => "292" ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib0115" "etiqueta" => "23" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Intra-articular implantation of autologous bone marrow-derived mesenchymal stromal cells to treat knee osteoarthritis: a randomized, triple-blind, placebo-controlled phase 1/2 clinical trial" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Emadedin" 1 => "N. Labibzadeh" 2 => "M.G. Liastani" 3 => "A. Karimi" 4 => "N. Jaroughi" 5 => "T. Bolurieh" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jcyt.2018.08.005" "Revista" => array:6 [ "tituloSerie" => "Cytotherapy." "fecha" => "2018" "volumen" => "20" "paginaInicial" => "1238" "paginaFinal" => "1246" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30318332" "web" => "Medline" ] ] ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib0120" "etiqueta" => "24" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Safety, tolerability and efficacy of intra-articular Progenza in knee osteoarthritis: a randomized double-blind placebo-controlled single ascending dose study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "D. Kuah" 1 => "S. Sivell" 2 => "T. Longworth" 3 => "K. James" 4 => "A. Guermazi" 5 => "F. Cicuttini" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/s12967-018-1420-z" "Revista" => array:6 [ "tituloSerie" => "J Transl Med." "fecha" => "2018" "volumen" => "16" "paginaInicial" => "49" "paginaFinal" => "62" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29510712" "web" => "Medline" ] ] ] ] ] ] ] ] 24 => array:3 [ "identificador" => "bib0125" "etiqueta" => "25" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Intra-articular injection of two different doses of autologous bone marrow mesenchymal stem cells versus hyaluronic acid in the treatment of knee osteoarthritis: long-term follow up of a multicenter randomized controlled clinical trial (phase I/II)" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J. Lamo-Espinosa" 1 => "G. Mora" 2 => "J. Blanco" 3 => "F. Granero-Moltó" 4 => "J. Núñez-Córdoba" 5 => "S. López-Elío" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "J Transl Med." "fecha" => "2018" "volumen" => "16" "paginaInicial" => "2013" ] ] ] ] ] ] 25 => array:3 [ "identificador" => "bib0130" "etiqueta" => "26" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Adipose-derived mesenchymal stem cell therapy in the treatment of knee osteoarthritis: a randomized controlled trial" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J. Freitag" 1 => "D. Bates" 2 => "J. Wickham" 3 => "K. Shah" 4 => "L. Huguenin" 5 => "A. Tenen" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2217/rme-2018-0161" "Revista" => array:6 [ "tituloSerie" => "Regen Med." "fecha" => "2019" "volumen" => "14" "paginaInicial" => "213" "paginaFinal" => "230" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30762487" "web" => "Medline" ] ] ] ] ] ] ] ] 26 => array:3 [ "identificador" => "bib0135" "etiqueta" => "27" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The role of stromal stem cells in tissue regeneration and wound repair" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "T.S. Stappenbeck" 1 => "H. Miyoshi" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1126/science.1172687" "Revista" => array:6 [ "tituloSerie" => "Science." "fecha" => "2009" "volumen" => "324" "paginaInicial" => "1666" "paginaFinal" => "1669" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19556498" "web" => "Medline" ] ] ] ] ] ] ] ] 27 => array:3 [ "identificador" => "bib0140" "etiqueta" => "28" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Second-look arthroscopic evaluation of cartilage lesions after mesenchymal stem cell implantation in osteoarthritic knees" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "Y.G. Koh" 1 => "Y.J. Choi" 2 => "O.R. Kwon" 3 => "Y.S. Kim" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/0363546514529641" "Revista" => array:6 [ "tituloSerie" => "Am J Sports Med." "fecha" => "2014" "volumen" => "42" "paginaInicial" => "1628" "paginaFinal" => "1637" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24743139" "web" => "Medline" ] ] ] ] ] ] ] ] 28 => array:3 [ "identificador" => "bib0145" "etiqueta" => "29" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Safety of intra-articular cell-therapy with culture-expanded stem cells in humans: a systematic literature review" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "C.M. Peeters" 1 => "M.J. Leijs" 2 => "M Reijman" 3 => "GJ van Osch" 4 => "PK Bos" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Osteoarthr Cartil." "fecha" => "2013" "volumen" => "21" "paginaInicial" => "1465" "paginaFinal" => "1473" ] ] ] ] ] ] 29 => array:3 [ "identificador" => "bib0150" "etiqueta" => "30" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Umbilical cord-derived mesenchymal stromal cells (MSCs) for knee osteoarthritis: repeated MSC dosing is superior to a single MSC dose and to hyaluronic acid in a controlled randomized phase I/II trial" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J. Matas" 1 => "M. Orrego" 2 => "D. Amenabar" 3 => "C. Infante" 4 => "R. Tapia-Limonchi" 5 => "M.I. Cadiz" ] ] ] ] ] "host" => array:2 [ 0 => array:2 [ "doi" => "10.1002/sctm.18-0053" "Revista" => array:6 [ "tituloSerie" => "Stem Cells Transl Med." "fecha" => "2019" "volumen" => "8" "paginaInicial" => "215" "paginaFinal" => "224" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30592390" "web" => "Medline" ] ] ] ] 1 => array:2 [ "doi" => "10.1002/sctm.18-0053" "WWW" => array:1 [ "link" => "https://doi.org/10.1002/sctm.18-0053" ] ] ] ] ] ] 30 => array:3 [ "identificador" => "bib0155" "etiqueta" => "31" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Safety and efficacy of allogenic placental mesenchymal stem cells for treating knee osteoarthritis: a pilot study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "S. Khalifeh Soltani" 1 => "B. Forogh" 2 => "N. Ahmadbeigi" 3 => "H. Hadizadeh Kharazi" 4 => "K. Fallahzadeh" 5 => "L. Kashani" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jcyt.2018.11.003" "Revista" => array:6 [ "tituloSerie" => "Cytotherapy." "fecha" => "2019" "volumen" => "21" "paginaInicial" => "54" "paginaFinal" => "63" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30522806" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/21735743/0000001800000001/v1_202201261003/S2173574321001106/v1_202201261003/en/main.assets" "Apartado" => array:4 [ "identificador" => "8383" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Review Article" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/21735743/0000001800000001/v1_202201261003/S2173574321001106/v1_202201261003/en/main.pdf?idApp=UINPBA00004M&text.app=https://reumatologiaclinica.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574321001106?idApp=UINPBA00004M"]

Statistics

Review Article

Expanded Mesenchymal Stromal Cells in knee osteoarthritis: A systematic literature review

Tratamiento de la artrosis de rodilla con células mesenquimales estromales expandidas: revisión sistemática de la literatura

Paloma Álvarez Hernández, José de la Mata Llord

Corresponding author

drdelamata@institutoari.com

Corresponding author.

Instituto de Salud Osteoarticular ARI, Madrid, Spain

Read

3177

Times
was read the article

1025

Total PDF

2152

Total HTML

Share statistics

 array:24 [
  "pii" => "S2173574321001106"
  "issn" => "21735743"
  "doi" => "10.1016/j.reumae.2020.10.001"
  "estado" => "S300"
  "fechaPublicacion" => "2022-01-01"
  "aid" => "1488"
  "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46; and Sociedad Espa&#241;ola de Reumatolog&#237;a y Colegio Mexicano de Reumatolog&#237;a"
  "copyrightAnyo" => "2020"
  "documento" => "article"
  "crossmark" => 1
  "subdocumento" => "rev"
  "cita" => "Reumatol Clin. 2022;18:49-55"
  "abierto" => array:3 [
    "ES" => false
    "ES2" => false
    "LATM" => false
  ]
  "gratuito" => false
  "lecturas" => array:1 [
    "total" => 0
  ]
  "Traduccion" => array:1 [
    "es" => array:19 [
      "pii" => "S1699258X20302448"
      "issn" => "1699258X"
      "doi" => "10.1016/j.reuma.2020.10.007"
      "estado" => "S300"
      "fechaPublicacion" => "2022-01-01"
      "aid" => "1488"
      "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46; and Sociedad Espa&#241;ola de Reumatolog&#237;a y Colegio Mexicano de Reumatolog&#237;a"
      "documento" => "article"
      "crossmark" => 1
      "subdocumento" => "rev"
      "cita" => "Reumatol Clin. 2022;18:49-55"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:1 [
        "total" => 0
      ]
      "es" => array:13 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Revisi&#243;n</span>"
        "titulo" => "Tratamiento de la artrosis de rodilla con c&#233;lulas mesenquimales estromales expandidas&#58; revisi&#243;n sistem&#225;tica de la literatura"
        "tienePdf" => "es"
        "tieneTextoCompleto" => "es"
        "tieneResumen" => array:2 [
          0 => "es"
          1 => "en"
        ]
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "49"
            "paginaFinal" => "55"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "en" => array:1 [
            "titulo" => "Expanded Mesenchymal Stromal Cells in Knee Osteoarthritis&#58; A Systematic Literature Review"
          ]
        ]
        "contieneResumen" => array:2 [
          "es" => true
          "en" => true
        ]
        "contieneTextoCompleto" => array:1 [
          "es" => true
        ]
        "contienePdf" => array:1 [
          "es" => true
        ]
        "resumenGrafico" => array:2 [
          "original" => 0
          "multimedia" => array:7 [
            "identificador" => "fig0005"
            "etiqueta" => "Figura 1"
            "tipo" => "MULTIMEDIAFIGURA"
            "mostrarFloat" => true
            "mostrarDisplay" => false
            "figura" => array:1 [
              0 => array:4 [
                "imagen" => "gr1.jpeg"
                "Alto" => 2256
                "Ancho" => 2167
                "Tamanyo" => 207375
              ]
            ]
            "descripcion" => array:1 [
              "es" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Diagrama de flujo&#46;</p>"
            ]
          ]
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "Paloma &#193;lvarez Hern&#225;ndez, Jos&#233; de la Mata Llord"
            "autores" => array:2 [
              0 => array:2 [
                "nombre" => "Paloma"
                "apellidos" => "&#193;lvarez Hern&#225;ndez"
              ]
              1 => array:2 [
                "nombre" => "Jos&#233;"
                "apellidos" => "de la Mata Llord"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "es"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "S2173574321001106"
          "doi" => "10.1016/j.reumae.2020.10.001"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => false
            "ES2" => false
            "LATM" => false
          ]
          "gratuito" => false
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574321001106?idApp=UINPBA00004M"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X20302448?idApp=UINPBA00004M"
      "url" => "/1699258X/0000001800000001/v1_202201120658/S1699258X20302448/v1_202201120658/es/main.assets"
    ]
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S2173574321000745"
    "issn" => "21735743"
    "doi" => "10.1016/j.reumae.2020.07.012"
    "estado" => "S300"
    "fechaPublicacion" => "2022-01-01"
    "aid" => "1463"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46; and Sociedad Espa&#241;ola de Reumatolog&#237;a y Colegio Mexicano de Reumatolog&#237;a"
    "documento" => "simple-article"
    "crossmark" => 1
    "subdocumento" => "crp"
    "cita" => "Reumatol Clin. 2022;18:56-8"
    "abierto" => array:3 [
      "ES" => false
      "ES2" => false
      "LATM" => false
    ]
    "gratuito" => false
    "lecturas" => array:1 [
      "total" => 0
    ]
    "en" => array:13 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Case Report</span>"
      "titulo" => "Digital ischemia as the initial presentation of catastrophic antiphospholipid syndrome"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "56"
          "paginaFinal" => "58"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Isquemia digital como forma de presentaci&#243;n de s&#237;ndrome antifosfol&#237;pido catastr&#243;fico pedi&#225;trico"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:8 [
          "identificador" => "fig0005"
          "etiqueta" => "Fig&#46; 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 1449
              "Ancho" => 1750
              "Tamanyo" => 238976
            ]
          ]
          "detalles" => array:1 [
            0 => array:3 [
              "identificador" => "at0005"
              "detalle" => "Fig&#46; "
              "rol" => "short"
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Digital ischaemia at onset and its evolution after treatment&#46; A and B&#41; Digital ischaemia and vasculitic lesions on palms of hands at onset&#46; C and D&#41; Improvement after one month of treatment&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Laura Mart&#237;n Pedraz, Roc&#237;o Galindo Zavala, Francisco Nieto Vega, Irene S&#225;nchez Baz&#225;n, Esmeralda N&#250;&#241;ez Cuadros"
          "autores" => array:5 [
            0 => array:2 [
              "nombre" => "Laura"
              "apellidos" => "Mart&#237;n Pedraz"
            ]
            1 => array:2 [
              "nombre" => "Roc&#237;o"
              "apellidos" => "Galindo Zavala"
            ]
            2 => array:2 [
              "nombre" => "Francisco"
              "apellidos" => "Nieto Vega"
            ]
            3 => array:2 [
              "nombre" => "Irene"
              "apellidos" => "S&#225;nchez Baz&#225;n"
            ]
            4 => array:2 [
              "nombre" => "Esmeralda"
              "apellidos" => "N&#250;&#241;ez Cuadros"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S1699258X20301972"
        "doi" => "10.1016/j.reuma.2020.07.013"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X20301972?idApp=UINPBA00004M"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574321000745?idApp=UINPBA00004M"
    "url" => "/21735743/0000001800000001/v1_202201261003/S2173574321000745/v1_202201261003/en/main.assets"
  ]
  "itemAnterior" => array:19 [
    "pii" => "S2173574321000630"
    "issn" => "21735743"
    "doi" => "10.1016/j.reumae.2020.07.008"
    "estado" => "S300"
    "fechaPublicacion" => "2022-01-01"
    "aid" => "1459"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46; and Sociedad Espa&#241;ola de Reumatolog&#237;a y Colegio Mexicano de Reumatolog&#237;a"
    "documento" => "article"
    "crossmark" => 1
    "subdocumento" => "fla"
    "cita" => "Reumatol Clin. 2022;18:42-8"
    "abierto" => array:3 [
      "ES" => false
      "ES2" => false
      "LATM" => false
    ]
    "gratuito" => false
    "lecturas" => array:1 [
      "total" => 0
    ]
    "en" => array:13 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Original Article</span>"
      "titulo" => "Pregnancy and systemic lupus erythematosus in Spain&#58; Has anything changed in the 21st century&#63;"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "42"
          "paginaFinal" => "48"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Embarazo y lupus eritematoso sist&#233;mico en Espa&#241;a&#58; &#191;ha cambiado algo en el siglo <span class="elsevierStyleSmallCaps">xxi</span>&#63;"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:8 [
          "identificador" => "fig0005"
          "etiqueta" => "Fig&#46; 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:2 [
            0 => array:1 [
              "imagen" => "gr1a.jpeg"
            ]
            1 => array:1 [
              "imagen" => "gr1b.jpeg"
            ]
          ]
          "detalles" => array:1 [
            0 => array:3 [
              "identificador" => "at0005"
              "detalle" => "Fig&#46; "
              "rol" => "short"
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Clinical and serological evolution of the SLE in pregnant patients and during postpartum period&#46;</p> <p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">&#40;A&#41; Evolution of the mean values of SLEDAI&#47;SLEPDAI from the visit prior to pregnancy up until the postpartum period&#59; &#40;B&#41; the percentage of patients with serology is shown &#40;anti-DNA&#8239;&#43;&#8239;and reduce complement&#41; changed during the same period&#46;</p> <p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Post P&#58; postpartum visit&#59; Pre E&#58; pre-conception visitor r visit prior to pregnancy&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Manuel de la Hera Madrazo, Pedro Mu&#241;oz Cacho, Leyre Riancho Zarrabeitia, Lorena &#193;lvarez Rodr&#237;guez, Ana Haya, Marcos L&#243;pez-Hoyos, V&#237;ctor M&#46; Mart&#237;nez-Taboada"
          "autores" => array:7 [
            0 => array:2 [
              "nombre" => "Manuel"
              "apellidos" => "de la Hera Madrazo"
            ]
            1 => array:2 [
              "nombre" => "Pedro"
              "apellidos" => "Mu&#241;oz Cacho"
            ]
            2 => array:2 [
              "nombre" => "Leyre"
              "apellidos" => "Riancho Zarrabeitia"
            ]
            3 => array:2 [
              "nombre" => "Lorena"
              "apellidos" => "&#193;lvarez Rodr&#237;guez"
            ]
            4 => array:2 [
              "nombre" => "Ana"
              "apellidos" => "Haya"
            ]
            5 => array:2 [
              "nombre" => "Marcos"
              "apellidos" => "L&#243;pez-Hoyos"
            ]
            6 => array:2 [
              "nombre" => "V&#237;ctor M&#46;"
              "apellidos" => "Mart&#237;nez-Taboada"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S1699258X20301935"
        "doi" => "10.1016/j.reuma.2020.07.009"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X20301935?idApp=UINPBA00004M"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574321000630?idApp=UINPBA00004M"
    "url" => "/21735743/0000001800000001/v1_202201261003/S2173574321000630/v1_202201261003/en/main.assets"
  ]
  "en" => array:20 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Review Article</span>"
    "titulo" => "Expanded Mesenchymal Stromal Cells in knee osteoarthritis&#58; A systematic literature review"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "49"
        "paginaFinal" => "55"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "Paloma &#193;lvarez Hern&#225;ndez, Jos&#233; de la Mata Llord"
        "autores" => array:2 [
          0 => array:2 [
            "nombre" => "Paloma"
            "apellidos" => "&#193;lvarez Hern&#225;ndez"
          ]
          1 => array:4 [
            "nombre" => "Jos&#233;"
            "apellidos" => "de la Mata Llord"
            "email" => array:1 [
              0 => "drdelamata@institutoari.com"
            ]
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "&#42;"
                "identificador" => "cor0005"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:2 [
            "entidad" => "Instituto de Salud Osteoarticular ARI&#44; Madrid&#44; Spain"
            "identificador" => "aff0005"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Corresponding author&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Tratamiento de la artrosis de rodilla con c&#233;lulas mesenquimales estromales expandidas&#58; revisi&#243;n sistem&#225;tica de la literatura"
      ]
    ]
    "resumenGrafico" => array:2 [
      "original" => 0
      "multimedia" => array:8 [
        "identificador" => "fig0005"
        "etiqueta" => "Fig&#46; 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 2256
            "Ancho" => 2167
            "Tamanyo" => 231245
          ]
        ]
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at0005"
            "detalle" => "Fig&#46; "
            "rol" => "short"
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Flow diagram&#46;</p>"
        ]
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0065">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">Advanced cellular therapies are one of the most cutting edge fields in the treatment of osteoarthritis&#46; These are seemingly safe treatments which prospectively fulfil the dual notion of modifying symptom and structure&#46; The greatest protagonist stems from the adult progenitor cells&#44; since they have greater biologic plasticity than the differentiated adult cells &#40;chondrocytes&#41; and are safer than the embryonic progenitor cells&#46; Mesenchymal Stromal Cells &#91;MSCs&#93; are adult progenitor cells derived from the embryonic mesoderm with a marked capacity for self-renewal and depending on the microenvironment in which they are found&#44; adult cells of different mesenchymal lineages may be differentiated &#40;chondrocyte&#44; osteoblast&#44; aipocyte&#44; myocyte and tenocyte&#41;&#46;<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> This double condition &#40;self-renewal and differentiation&#41; makes them extraordinarily attractive for regenerative strategies of mesenchymal tissues&#44; such as cartilage or bone&#46;<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a> In animal models of osteoarthritis&#44; MSCs have reproducibly shown their marked ability to repair chondral damage&#44; detain progression and improve symptoms&#46;<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> However&#44; clinical experiences with MSCs have not been able to reproduce these virtues&#44; offering a panorama of mixed&#44; inconsistent results&#46;<a class="elsevierStyleCrossRefs" href="#bib0020"><span class="elsevierStyleSup">4&#44;5</span></a> Part of this discrepancy may be explained by the notable terminological confusion surrounding the treatment with <span class="elsevierStyleItalic">stem cells</span>&#46; Rather than a single therapy&#44; this involves several very different cellular treatments&#46;<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">6</span></a> The most commonly used in clinical practice are characterized by minimal tissue manipulation&#44; marked cellular heterogeneity&#44; a great wealth of growth factors and&#44; above all&#44; a marginal proportion of MSCs&#46;<a class="elsevierStyleCrossRefs" href="#bib0035"><span class="elsevierStyleSup">7&#44;8</span></a> In these treatments&#44; it is highly complex to discriminate the therapeutic role of the MSCs due to the large quantity of therapeutic agents &#40;potentially&#41; involved&#46;</p><p id="par0010" class="elsevierStylePara elsevierViewall">In order to determine the efficacy and safety of MSCs in osteoarthritis&#44; we did a systematic review of the literature &#40;SRL&#41; which evaluated the treatment of osteoarthritis knees with intra-articular implants of expanded MSC&#44; without scaffolds or surgical co-treatments&#46;</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0070">Material and methods</span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0075">Search strategy</span><p id="par0015" class="elsevierStylePara elsevierViewall">A sensitive search was performed in Medline&#44; Cochrane Library and Embassy &#40;up to February 2018&#41; designed by an expert documentalist &#40;MA&#41;&#44; using Mesh and free text terms in English and Spanish &#40;<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>&#41;&#46; The aim was to identify relevant publications which could have been overlooked&#46; The electronic search was complemented with a manual search into the references of the selected studies&#46;</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0080">Study selection</span><p id="par0020" class="elsevierStylePara elsevierViewall">Study selection was made jointly by 2 reviewers &#40;PA&#41; and &#40;JM&#41; in 2 phases&#58; 1&#41; selection by titles and abstracts&#59; 2&#41; recompilation of the complete text with selected references&#46; The said references were analysed by looking at previously established inclusion criteria&#58; adult patients &#40;N&#8239;&#8805;&#8239;10&#41;&#44; with moderate-severe osteoarthritis of the knee &#40;grade II-IV Kellgren-Lawrence&#41;&#44; treated with at least one intra-articular injection of MSCs &#40;according to the phenotype criteria of the ISCT&#41;<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">9</span></a> and with minimum follow-up of 6 months&#46; Exclusively level I studies were considered for inclusion&#58; meta-analyses&#44; systematic reviews of prospective studies&#44; randomised clinical trials with control group &#40;randomised controlled trials &#41; &#91;RCT&#93;&#41; and with no control group &#40;quasi-experimental clinical trials&#41; &#91;QCT&#93;&#41;&#46; The following were excluded&#58; observational studies and intra-articular interventions with cellular populations which did not meet with ISCT criteria&#46; Equally&#44; those trials where treatment was administered together with co-interventions with scaffolds or surgical procedures were excluded&#46;</p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0085">Data collection and assessment of quality</span><p id="par0025" class="elsevierStylePara elsevierViewall">Data collection of selected publications was carried out by one of the reviewers &#40;PA&#41; with the use of specific&#44; pre-designed templates&#46; When doubt ensued for inclusion of a study&#44; a second critical reading was made by the second reviewer &#40;JM&#41;&#46; The final inclusion was determined by consensus&#46; Final data collected in templates were used for the creation of the final summary of findings table&#46;</p><p id="par0030" class="elsevierStylePara elsevierViewall">The quality of the evidence was ranked according to the scale of the Scottish Intercollegiate Guidelines Network &#40;SIGN&#41;&#46;<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">10</span></a> The SIGN method places particular emphasis on quantitative analysis provided by the SRL and also places importance on the reduction of systematic error or bias&#46;</p></span></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0090">Results</span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0095">Study description</span><p id="par0035" class="elsevierStylePara elsevierViewall">The electronic search identified 252 references &#40;18 duplicates were ruled out&#41;&#46; After Reading the title and abstract 222 studies were excluded&#46; Twelve relevant articles were selected for critical reading &#40;<a class="elsevierStyleCrossRef" href="#fig0005">Fig&#46; 1</a>&#41;&#46; Nine met with the inclusion critieria<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">11&#8211;19</span></a> and 3 were excluded &#40;2 made with cellular implants which did not meet with ISCT<a class="elsevierStyleCrossRefs" href="#bib0100"><span class="elsevierStyleSup">20&#44;21</span></a> criteria and one observational study<a class="elsevierStyleCrossRef" href="#bib0110"><span class="elsevierStyleSup">22</span></a>&#41;&#46; The body of evidence consisted of 9 clinical trials where 169 patients were treated with MSCs &#40;61&#46;8&#37; women and 38&#46;1&#37; men&#41;&#46; All clinical trials were concept tests &#40;Phase I-II&#41;&#44; 3 RCT controlled with hyaluronic acid &#40;HA&#41;<a class="elsevierStyleCrossRefs" href="#bib0060"><span class="elsevierStyleSup">12&#44;14&#44;19</span></a> and 6 QCT&#46;<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">11&#44;13&#44;15&#8211;18</span></a> No clinical efficacy trial &#40;Phase III&#41; met with inclusion criteria&#46; One hundred and fifteen patients were treated with MSCs obtained from bone marrow<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">11&#44;12&#44;14&#44;15</span></a><span class="elsevierStyleSup">&#44;</span><a class="elsevierStyleCrossRefs" href="#bib0085"><span class="elsevierStyleSup">17&#44;19</span></a> and 54 with MSCs from adipose tissue&#46;<a class="elsevierStyleCrossRefs" href="#bib0065"><span class="elsevierStyleSup">13&#44;16&#44;18</span></a> Two studies used more than one dose of MSCs<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">11&#44;18</span></a> and 2 used allergenic MSCs implants&#46;<a class="elsevierStyleCrossRefs" href="#bib0060"><span class="elsevierStyleSup">12&#44;19</span></a> Follow-up times ranged between 6 and 24 months&#46; The quality of the evidence assigned was the lowest of that contemplated in the SIGN scale for clinical trials &#40;SIGN 1&#8722;&#41;&#44; due to the low sample number of studies and that the majority of trials had no control group &#40;<a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>&#41;&#46;</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><elsevierMultimedia ident="tbl0010"></elsevierMultimedia></span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0100">Results of efficacy</span><p id="par0040" class="elsevierStylePara elsevierViewall">Efficacy of intra-articular treatment with MSCs was assessed clinically and structurally&#46;</p><span id="sec0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0105">Clinical efficacy</span><p id="par0045" class="elsevierStylePara elsevierViewall">Two controlled studies reported significant improvement regarding hyaluronic acid&#46;<a class="elsevierStyleCrossRefs" href="#bib0070"><span class="elsevierStyleSup">14&#44;19</span></a> Lamo-Espinosa et al&#46;<a class="elsevierStyleCrossRef" href="#bib0070"><span class="elsevierStyleSup">14</span></a> found there was an analgesic improvement &#40;VAS&#41; with all doses used&#46; This improvement was progressive from the third month until the maximum of one year&#46; The WOMAC improvement was only observed in patients treated with high doses and was later &#40;one year&#41; &#40;<a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>&#41;&#46; In the other RCT&#44; the magnitude of the analgesic and functional improvement was greater than that of the HA from 6&#8239;m onwards and it also reached its maximum at one year&#46;<a class="elsevierStyleCrossRef" href="#bib0095"><span class="elsevierStyleSup">19</span></a> The third RCT included was adjusted to the same time curve with a maximum response at one year&#44; but with no significant differences regarding HA&#46;<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">12</span></a></p><p id="par0050" class="elsevierStylePara elsevierViewall">All QCT reported clinical improvement with respect to their baseline situation &#40;<a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>&#41;&#46; In several studies the analgesic benefit &#40;VAS and WOMAC pain&#41; was observed from 3 months onwards&#46;<a class="elsevierStyleCrossRefs" href="#bib0075"><span class="elsevierStyleSup">15&#8211;17</span></a> However&#44; the improvement of the other functional measurements &#40;not just analgesic ones&#41; did not occur until 6 months&#46; Like with the RCT&#44; the maximum peak clinical benefit was reported one year after implant&#46; This response was maintained in some patients until 24 months&#46;<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">11&#44;13&#44;18</span></a> In general&#44; the clinical response was more consistent in patients treated with the highest doses&#46;<a class="elsevierStyleCrossRefs" href="#bib0065"><span class="elsevierStyleSup">13&#44;16&#44;18</span></a></p></span></span><span id="sec0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0110">Structural efficacy</span><p id="par0055" class="elsevierStylePara elsevierViewall">The structural modifying effect of the implant with MSCs was reported in 2 RCT<a class="elsevierStyleCrossRefs" href="#bib0070"><span class="elsevierStyleSup">14&#44;19</span></a> and 5 QCT&#46;<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">11&#44;13&#44;15&#44;17</span></a><span class="elsevierStyleSup">&#44;</span><a class="elsevierStyleCrossRef" href="#bib0090"><span class="elsevierStyleSup">18</span></a> In the RCT&#44; the structural benefit was significant with regard to the HA from one year onwards&#46; After 12 months of implant&#44; patients with MSCs showed a significant reduction in joint space&#44;<a class="elsevierStyleCrossRef" href="#bib0070"><span class="elsevierStyleSup">14</span></a> in the Whole-Organ Magnetic Resonance Imaging Score &#40;WORMS&#41;<a class="elsevierStyleCrossRef" href="#bib0070"><span class="elsevierStyleSup">14</span></a> and the low quality cartilage area &#40;PCI&#41;<a class="elsevierStyleCrossRef" href="#bib0095"><span class="elsevierStyleSup">19</span></a> &#40;<a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>&#41;&#46; This structurally modifying effect was only observed in patients treated with doses &#8805;40&#8239;&#215;&#8239;10<span class="elsevierStyleSup">6</span> MSCs&#46; In the QCT&#44; the structural benefit was shown by a lower narrowing of the medial space&#44;<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">13</span></a> a reduction of the area of chondral defects&#44;<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">13</span></a> of the T2 map of the collagen composition<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">17</span></a> and by an increase in cartilage thickness&#46;<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">11&#44;13&#44;18</span></a> These changes were reported one year after implant although the reduction of the PCI was observed from 6 months onwards&#46;<a class="elsevierStyleCrossRef" href="#bib0075"><span class="elsevierStyleSup">15</span></a> Like in the RCT&#44; patients with the most consistent improvements were those who received the highest dose of MSCs &#40;&#8805;40&#8239;&#215;&#8239;10<span class="elsevierStyleSup">6</span>&#41;&#46;<a class="elsevierStyleCrossRefs" href="#bib0065"><span class="elsevierStyleSup">13&#44;15&#44;17&#44;1</span></a></p></span><span id="sec0055" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0115">Safety results</span><p id="par0060" class="elsevierStylePara elsevierViewall">Safety data coincided in all studies&#46; Intra-articular injection of MSCs was a well tolerated and safe intervention in all patients&#46; Factors such as dose &#40;high or low number of MSCs&#41;&#44; administration regimen &#40;one or more injections&#41;&#44; source of MSCs &#40;adipose tissue or bone marrow&#41; and type of transplant &#40;autologous or allergenic&#41; did not alter favourable tolerance&#46; Systemic reactions associated with treatment were not described&#44; and only one case of hospital admission was reported&#44; due to synovial fluid effusion which evolved favourably in 24&#8239;h&#46;<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">12</span></a> The most common side effect was the appearance of minor local reaction &#40;pain and&#47;or inflammation&#41; in the puncture site &#40;13&#37;&#8211;53&#37; of patients&#41; &#40;<a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>&#41;&#46; In all cases&#44; symptoms were temporary and treated locally with ice &#40;occasionally with anti-inflammatories&#41; in under 7 days&#46; In the controlled studies&#44; the incidence of these local effects did not present with any significant differences to those observed in patients treated with HA&#46;<a class="elsevierStyleCrossRefs" href="#bib0060"><span class="elsevierStyleSup">12&#44;14&#44;19</span></a></p></span></span><span id="sec0060" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0120">Discussion</span><p id="par0065" class="elsevierStylePara elsevierViewall">The immunomodulator and regenerative potential of MSCs has positioned this type of therapy as one of the most promising in the therapeutic panorama of osteoarthritis&#46; The use of <span class="elsevierStyleItalic">stem cells</span> in regenerative cartilage strategies is a highly appealing but also widely debated subject&#46; This is the first SRL to analyse cellular treatment with quantifiable and phenotypically homogeneous MSCs implants&#46; Our safety results coincide with previous studies<a class="elsevierStyleCrossRefs" href="#bib0020"><span class="elsevierStyleSup">4&#44;5</span></a> and confirm that the expanded MSCs implant is a well tolerated and safe intervention&#44; with no systemic toxicity&#46; A significant percentage of patients suffered pain and&#47;or local inflammation but this was temporary&#44; insignificant and very similar to that of other intra-articular treatments&#46; In general&#44; it seems to occur more commonly in those patients treated with higher cellular doses and&#47;or with higher injection volumes&#46;</p><p id="par0070" class="elsevierStylePara elsevierViewall">We were unable to reach a conclusion regarding the efficacy of MSCs from the evidence&#46; The 9 concept test studies included&#44; although prospective&#44; were markedly biased by the low sample size&#44; insufficient statistical power and lack of a control group&#46; However&#44; interesting conclusions were providing relating to their foundation and their possible utility in osteoarthritis&#46; In this respect&#44; the implant of MSCs showed a greater &#40;and more sustained&#41; clinical benefit than HA&#46;<a class="elsevierStyleCrossRefs" href="#bib0070"><span class="elsevierStyleSup">14&#44;19</span></a> This analgesic-functional improvement required a latency period greater than that observed with HA&#46; Characteristically&#44; analgesic improvement occurs at the beginning which precedes a more complete functional improvement&#46; This early analgesia is a characteristic which has been confirmed by other studies&#44;<a class="elsevierStyleCrossRef" href="#bib0115"><span class="elsevierStyleSup">23</span></a> and has been linked to an initial paracrine and anti-inflammatory action of the implant&#46; The potential of the MSCs self-renewal and differentiation would lead months later to the structural improvement observed at one year&#46;<a class="elsevierStyleCrossRef" href="#bib0120"><span class="elsevierStyleSup">24</span></a> From our results it may be deduced that the clinical and structural benefit produced by the MSCs may become quite sustained over time &#40;up to 2 years&#41;<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">11&#44;13&#44;18</span></a> Recent studies appear to confirm this virtue&#44; communicating stable clinical and structural improvements up to 4 years after the implant&#46;<a class="elsevierStyleCrossRef" href="#bib0125"><span class="elsevierStyleSup">25</span></a> One unanswered question from this review is the ideal cellular dose with which the maximum clinical and structural benefit may be obtained&#46; Approximately&#44; the most complete clinical improvements and the most notable radiologic changes were obtained with equal or higher doses to a 40&#8239;&#215;&#8239;10<span class="elsevierStyleSup">6</span> cells&#46; This cut-off point appears to coincide with a range reported in the literature which&#44; in general&#44; inclines towards equal or higher doses&#46;<a class="elsevierStyleCrossRef" href="#bib0130"><span class="elsevierStyleSup">26</span></a> However&#44; as occurs in some of the review trials&#44;<a class="elsevierStyleCrossRef" href="#bib0080"><span class="elsevierStyleSup">16</span></a> it is viable to say that there is analgesic improvement with a considerably lower doses&#46;<a class="elsevierStyleCrossRef" href="#bib0120"><span class="elsevierStyleSup">24</span></a> In view of this observation&#44; it would appear that to obtain a paracrine and anti-inflammatory effect cellular implants do not need to be used in such large quantities&#46;<a class="elsevierStyleCrossRef" href="#bib0135"><span class="elsevierStyleSup">27</span></a> Regarding the radiologic benefit&#44; our results confirm previous experiences which report an interesting regenerating effect of chondral damage&#46;<a class="elsevierStyleCrossRef" href="#bib0140"><span class="elsevierStyleSup">28</span></a> Singularly&#44; this is governed by a response pattern which is in keeping with the improvement of functional parameters&#58; significant from 6 months onwards and for a maximum of one year&#46; The consistency of this pattern could prove that chondral damage repair is necessary to provide a more complete clinical and improvement which does not appear in the first few months&#44; despite the analgesic benefit&#46;</p><p id="par0075" class="elsevierStylePara elsevierViewall">The results of this review should be interpreted with caution due to many limitations&#46; To those already mentioned&#44; such as the small sample size and main absence of a control group&#44; we should add selection biases and poor classification&#44; possibly accounted for by the fact that patients with the most severe osteoarthritis were those finally treated with MSCs&#46; The absence of masking meant it was highly possible then there was the added existence of assessment biases&#44; in which the intervention &#40;treatment with MSCs&#41; was particularly weighed by the assessor&#46; Despite being a well-defined intervention&#44; the great heterogeneity of dose and administration protocols was striking&#44; making it difficult to compare different treatments&#46; This heterogeneity is also applicable to the parameters which assessed radiologic damage&#46; The huge variability of measures chosen and the low sample seize impeded the drawing of consistent conclusions regarding the magnitude of the benefit or the determination of a dose-response pattern&#46;</p><p id="par0080" class="elsevierStylePara elsevierViewall">To sum up&#44; this review proposes a basis for the therapeutic use of expanded MSCs in osteoarthritis as a modifying treatment of symptoms and structure&#46; Its efficacy in clinical trials has been confirmed and it is a safe technique for patients&#44; and is viable for rheumatologists&#46; However&#44; to become a real and accessible alternative&#44; MSCs implants must also overcome other logistic and financial barriers&#46; In this sense the good safety results of the allergenic implants in the review&#44; validate previous experiences&#46;<a class="elsevierStyleCrossRef" href="#bib0145"><span class="elsevierStyleSup">29</span></a> They provide interesting clinical information in favour of the bio bank implants&#44; at a lower cost&#44; without discomfort for the patient and with higher logistic advantages&#46; Among these is access to MSCs from the umbilical cord which are widely available and also &#40;potentially&#41; effective in osteoarthritis of the knee&#46;<a class="elsevierStyleCrossRefs" href="#bib0150"><span class="elsevierStyleSup">30&#44;31</span></a> We will have to wait for the results of ongoing clinical trials to confirm whether this preliminary promising evidence materialises as consistent and reproducible benefits&#46;</p></span><span id="sec0065" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0125">Conflict of interests</span><p id="par0085" class="elsevierStylePara elsevierViewall">The authors have no conflict of interests to declare&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:10 [
        0 => array:3 [
          "identificador" => "xres1655532"
          "titulo" => "Abstract"
          "secciones" => array:4 [
            0 => array:2 [
              "identificador" => "abst0005"
              "titulo" => "Objective"
            ]
            1 => array:2 [
              "identificador" => "abst0010"
              "titulo" => "Methods"
            ]
            2 => array:2 [
              "identificador" => "abst0015"
              "titulo" => "Results"
            ]
            3 => array:2 [
              "identificador" => "abst0020"
              "titulo" => "Conclusions"
            ]
          ]
        ]
        1 => array:2 [
          "identificador" => "xpalclavsec1471557"
          "titulo" => "Keywords"
        ]
        2 => array:3 [
          "identificador" => "xres1655533"
          "titulo" => "Resumen"
          "secciones" => array:4 [
            0 => array:2 [
              "identificador" => "abst0025"
              "titulo" => "Objetivo"
            ]
            1 => array:2 [
              "identificador" => "abst0030"
              "titulo" => "M&#233;todos"
            ]
            2 => array:2 [
              "identificador" => "abst0035"
              "titulo" => "Resultados"
            ]
            3 => array:2 [
              "identificador" => "abst0040"
              "titulo" => "Conclusiones"
            ]
          ]
        ]
        3 => array:2 [
          "identificador" => "xpalclavsec1471556"
          "titulo" => "Palabras clave"
        ]
        4 => array:2 [
          "identificador" => "sec0005"
          "titulo" => "Introduction"
        ]
        5 => array:3 [
          "identificador" => "sec0010"
          "titulo" => "Material and methods"
          "secciones" => array:3 [
            0 => array:2 [
              "identificador" => "sec0015"
              "titulo" => "Search strategy"
            ]
            1 => array:2 [
              "identificador" => "sec0020"
              "titulo" => "Study selection"
            ]
            2 => array:2 [
              "identificador" => "sec0025"
              "titulo" => "Data collection and assessment of quality"
            ]
          ]
        ]
        6 => array:3 [
          "identificador" => "sec0030"
          "titulo" => "Results"
          "secciones" => array:4 [
            0 => array:2 [
              "identificador" => "sec0035"
              "titulo" => "Study description"
            ]
            1 => array:3 [
              "identificador" => "sec0040"
              "titulo" => "Results of efficacy"
              "secciones" => array:1 [
                0 => array:2 [
                  "identificador" => "sec0045"
                  "titulo" => "Clinical efficacy"
                ]
              ]
            ]
            2 => array:2 [
              "identificador" => "sec0050"
              "titulo" => "Structural efficacy"
            ]
            3 => array:2 [
              "identificador" => "sec0055"
              "titulo" => "Safety results"
            ]
          ]
        ]
        7 => array:2 [
          "identificador" => "sec0060"
          "titulo" => "Discussion"
        ]
        8 => array:2 [
          "identificador" => "sec0065"
          "titulo" => "Conflict of interests"
        ]
        9 => array:1 [
          "titulo" => "References"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "fechaRecibido" => "2020-07-13"
    "fechaAceptado" => "2020-10-15"
    "PalabrasClave" => array:2 [
      "en" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec1471557"
          "palabras" => array:4 [
            0 => "Mesenchymal Stromal Cells"
            1 => "Knee osteoarthritis"
            2 => "Intra-articular treatment"
            3 => "Systematic literature review"
          ]
        ]
      ]
      "es" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec1471556"
          "palabras" => array:5 [
            0 => "C&#233;lulas mesenquimales estromales"
            1 => "C&#233;lulas madre"
            2 => "Artrosis de rodilla"
            3 => "Tratamiento intra-articular"
            4 => "Revisi&#243;n sistem&#225;tica"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:2 [
      "en" => array:3 [
        "titulo" => "Abstract"
        "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Objective</span><p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">To analyse the efficacy and safety of intra-articular injection of expanded Mesenchymal Stromal Cells &#40;MSCs&#41; in knee osteoarthritis&#46;</p></span> <span id="abst0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Methods</span><p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Systematic Literature Review&#46; A pre-defined search strategy was run in Medline&#44; Embase and Cochrane Library until February 2018&#46; Inclusion criteria&#58; knee osteoarthritis &#40;grades II-IV Kellgren-Lawrence&#41;&#59; intra-articular injection of MSCs &#40;without surgical co-treatments&#41;&#59; Randomized Controlled Trials &#40;RCTs&#41; or Quasi-experimental Clinical Trials &#40;QCTs&#41; N&#8239;&#8805;&#8239;10 and &#8805;6 months of follow-up were included&#46; Evidence was assigned according to the Scottish Intercollegiate Guidelines Network &#40;SIGN&#41;&#46;</p></span> <span id="abst0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0020">Results</span><p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">The search identified 252 articles&#46; Nine proof-of-concept trials &#40;3 RCTs&#44; 6 QCTs&#41; were included &#40;N&#8239;&#61;&#8239;169&#41;&#46; Evidence showed clinical improvement in 60&#37; of patients&#46; Structural benefit was reported in half of patients&#46; Clinical benefit was observed from the 3<span class="elsevierStyleSup">rd</span> month and structural improvement from the 6<span class="elsevierStyleSup">th</span>&#46; All studies reported maximum clinical and structural benefit a year following the implant&#46; This benefit was sustained for up to 24 months&#46; Studies with doses &#8805;40&#8239;&#215;&#8239;10<span class="elsevierStyleSup">6</span> showed more consistent clinical and structural benefits than those with lower doses&#46; No systemic adverse reactions were reported&#46; The most common adverse effect was pain and&#47;or inflammation in the puncture area &#40;13&#8211;53&#37;&#41;&#46; The use of donor cells was as safe as autologous implants&#46;</p></span> <span id="abst0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Conclusions</span><p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">Intra-articular implants of MSCs seem to be safe with no serious adverse effects&#46; Low-quality evidence precludes conclusions regarding efficacy in this review&#46; However&#44; the clinical and structural benefits observed provide a rationale for using expanded MSCs implants in osteoarthritis patients&#46; High-quality evidence trials are needed to further determine best protocols to maximize clinical and structural improvement&#46;</p></span>"
        "secciones" => array:4 [
          0 => array:2 [
            "identificador" => "abst0005"
            "titulo" => "Objective"
          ]
          1 => array:2 [
            "identificador" => "abst0010"
            "titulo" => "Methods"
          ]
          2 => array:2 [
            "identificador" => "abst0015"
            "titulo" => "Results"
          ]
          3 => array:2 [
            "identificador" => "abst0020"
            "titulo" => "Conclusions"
          ]
        ]
      ]
      "es" => array:3 [
        "titulo" => "Resumen"
        "resumen" => "<span id="abst0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Objetivo</span><p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Analizar la eficacia y la seguridad de los implantes de c&#233;lulas mesenquimales estromales expandidas &#40;MSCs&#44; por sus siglas en ingl&#233;s&#41; en la artrosis de rodilla&#46;</p></span> <span id="abst0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">M&#233;todos</span><p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">Revisi&#243;n sistem&#225;tica de la literatura&#46; Estrategia de b&#250;squeda en Medline&#44; Embase y Cochrane Library hasta febrero del 2018&#46; Inclusi&#243;n&#58; artrosis de rodilla &#40;II-IV Kellgren&#41;&#59; inyecci&#243;n intra-articular de MSCs&#59; ensayos controlados aleatorizados &#40;ECA&#41; y ensayos cl&#237;nicos cuasi-experimentales &#40;ECC&#41;&#8239;&#8805;&#8239;6 meses y N&#8239;&#8805;&#8239;10&#46;</p></span> <span id="abst0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">Resultados</span><p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">De 252 art&#237;culos identificados&#44; se incluyeron 3 ECA y 6 ECC &#40;N&#8239;&#61;&#8239;169&#41;&#46; El 60&#37; de los pacientes mejoraron cl&#237;nicamente y el 50&#37; estructuralmente hasta 2 a&#241;os despu&#233;s del implante&#46; El beneficio m&#225;ximo se alcanz&#243; al a&#241;o con dosis &#8805;40&#8239;&#215;&#8239;10<span class="elsevierStyleSup">6</span> MSCs&#46; La intervenci&#243;n fue bien tolerada&#44; igualmente segura en implantes alog&#233;nicos y aut&#243;logos&#46;</p></span> <span id="abst0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Conclusiones</span><p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">Las MSCs intra-articulares son seguras&#46; La baja calidad de la evidencia analizada no admite conclusiones sobre la eficacia&#44; pero prueba un fundamento para su uso en la artrosis como modificador de s&#237;ntoma y de estructura que debe ser constatado en ensayos de alta calidad&#46;</p></span>"
        "secciones" => array:4 [
          0 => array:2 [
            "identificador" => "abst0025"
            "titulo" => "Objetivo"
          ]
          1 => array:2 [
            "identificador" => "abst0030"
            "titulo" => "M&#233;todos"
          ]
          2 => array:2 [
            "identificador" => "abst0035"
            "titulo" => "Resultados"
          ]
          3 => array:2 [
            "identificador" => "abst0040"
            "titulo" => "Conclusiones"
          ]
        ]
      ]
    ]
    "NotaPie" => array:1 [
      0 => array:2 [
        "etiqueta" => "&#9734;"
        "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as&#58; &#193;lvarez Hern&#225;ndez P&#44; de la Mata Llord J&#46; Tratamiento de la artrosis de rodilla con c&#233;lulas mesenquimales estromales expandidas&#58; revisi&#243;n sistem&#225;tica de la literatura&#46; Reumatol Clin&#46; 2022&#59;18&#58;49&#8211;55&#46;</p>"
      ]
    ]
    "multimedia" => array:3 [
      0 => array:8 [
        "identificador" => "fig0005"
        "etiqueta" => "Fig&#46; 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 2256
            "Ancho" => 2167
            "Tamanyo" => 231245
          ]
        ]
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at0005"
            "detalle" => "Fig&#46; "
            "rol" => "short"
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Flow diagram&#46;</p>"
        ]
      ]
      1 => array:8 [
        "identificador" => "tbl0005"
        "etiqueta" => "Table 1"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at0010"
            "detalle" => "Table "
            "rol" => "short"
          ]
        ]
        "tabla" => array:1 [
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black"><span class="elsevierStyleBold">Pubmed</span> Results of the search&#58; 168&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">&#40;&#8220;Osteoarthritis&#44; Knee&#8221;&#91;Mesh&#93;&#41; AND &#40;&#40;&#40;&#40;&#40;&#40;&#40;&#40;&#40;&#40;&#40;&#8220;Stromal Cells&#8221;&#91;Mesh&#93;&#41; OR &#8220;Multipotent Stem Cells&#8221;&#91;Mesh&#93;&#41; OR &#8220;Mesenchymal Stromal Cells&#8221;&#91;Mesh&#93;&#41; OR &#8220;Stem Cells&#8221;&#91;Mesh&#93;&#41; OR &#8220;Fetal Stem Cells&#8221;&#91;Mesh&#93;&#41; OR &#8220;Pluripotent Stem Cells&#8221;&#91;Mesh&#93;&#41; OR &#8220;Embryonic Stem Cells&#8221;&#91;Mesh&#93;&#41; OR &#8220;Induced Pluripotent Stem Cells&#8221;&#91;Mesh&#93;&#41;&#41; OR &#40;&#40;&#8220;Stromal Cells&#8221;&#91;Title&#47;Abstract&#93; OR &#8220;Multipotent Stem Cells&#8221;&#91;Title&#47;Abstract&#93; OR &#8220;Mesenchymal Cells&#8221;&#91;Title&#47;Abstract&#93; OR &#8220;stem cell&#8221;&#91;Title&#47;Abstract&#93; OR &#8220;embryonic&#8221;&#91;Title&#47;Abstract&#93; OR &#8220;Induced Pluripotent Stem Cells&#8221; OR&#41;&#41;&#41; OR &#40;&#40;&#8220;Progenitor Cell&#42; Mesenchymal&#8221;&#91;Title&#47;Abstract&#93; OR &#8220;Mother Cell&#42;&#8221;&#91;Title&#47;Abstract&#93; OR &#8220;Colony-Forming Unit&#42;&#8221;&#91;Title&#47;Abstract&#93; OR &#8220;IPS Cell&#42;&#8221;&#91;Title&#47;Abstract&#93;&#41;&#41;&#41;&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Filters&#58; Spanish&#44; English&#44; humans&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleBold">Embase</span> Results of the search&#58; 25&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">&#40;knee NEAR&#47;3 osteoarthritis&#41; AND &#40;&#40;&#8216;stromal cell&#8217;&#47;de OR &#39;multipotent stem cell&#39;&#47;de OR &#39;stem cell&#39;&#47;de OR &#39;fetal stem cell&#39;&#47;de OR &#39;pluripotent stem cell&#39;&#47;de OR &#39;embryonic stem cell&#39;&#47;de OR &#39;induced pluripotent stem cell&#39;&#41; OR &#40;&#39;progenitor cell mesenchymal&#8217; OR &#39;mother cell&#39; OR &#39;colony forming unit&#39;&#41;&#41; AND &#91;embase&#93;&#47;lim NOT &#40;&#91;embase&#93;&#47;lim AND &#91;medline&#93;&#47;lim&#41; AND &#40;&#91;English&#93;&#47;lima OR &#91;Spanish&#93;&#47;lim&#41; AND &#91;humans&#93;&#47;lim&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Filers&#58; Spanish&#44; English&#44; humans&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleBold">Cochrane</span> Results of the search&#58; 59&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">&#91;mh &#8220;Osteoarthritis Knee&#8221;&#93; OR &#40;knee near&#47;3 osteoarthritis&#41; AND &#40;&#91;mh &#8220;Stromal Cells&#8221;&#93; or &#91;mh &#8220;Multipotent Stem Cells&#8221;&#93; or &#91;mh &#8220;Mesenchymal Stromal Cells&#8221;&#93; or &#91;mh &#8220;Stem Cells&#8221;&#93; or &#91;mh &#8220;Fetal Stem Cells&#8221;&#93; or &#91;mh &#8220;Pluripotent Stem Cells&#8221;&#93; or &#91;mh &#8220;Embryonic Stem Cells&#8221;&#93; or &#91;mh &#8220;Induced Pluripotent Stem Cells&#8221;&#93; OR &#40;&#8220;Stromal Cells&#8221; or &#8220;Multipotent Stem Cells&#8221; or &#8220;Mesenchymal Cells&#8221; or &#8220;stem cell&#8221; or &#8220;embryonic&#8221; or &#8220;Induced Pluripotent Stem Cells&#8221;&#41; OR &#40;&#39;stromal cells&#39; or &#39;multipotent stem cells&#39; or &#39;mesenchymal cells&#39; or &#39;stem cell&#39; or &#39;embryonic&#39; or &#39;induced pluripotent stem cells&#39;&#41; OR &#40;&#39;progenitor cell mesenchymal&#39; or &#39;mother cell&#39; or &#39;colony forming unit&#39;&#41;&#41;&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Filters&#58; Spanish&#44; English&#44; humans&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab2818055.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Search strategy&#46;</p>"
        ]
      ]
      2 => array:8 [
        "identificador" => "tbl0010"
        "etiqueta" => "Table 2"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at0015"
            "detalle" => "Table "
            "rol" => "short"
          ]
        ]
        "tabla" => array:2 [
          "leyenda" => "<p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">AT&#58; adipose tissue&#59; BB&#58; blood biochemistry&#59; BM&#58; bone marrow&#59; BMI&#58; body mass index&#59; EKG&#58; electrocardiogram&#59; HA&#58; hyaluronic acid&#59; HAQ&#58; Health Assessment Questionnaire&#59; ICOAP&#58; Intermittent &#38; Constant Osteoarthritis pain score&#59; KOOS&#58; Knee injury and Osteoarthritis Outcome Score&#59; KSS&#58; Knee Society clinical rating system&#59; KX&#58; knee X-ray&#59; NMR&#58; nuclear magnetic resonance&#59; NSAID&#58; non steroid anti inflammatory drugs&#59; PE&#58; physical examination&#59; PCI&#58; poor cartilage index&#59; PGA&#58; Patient Global Assessment&#59; Pl&#58; placebo&#59; QCT&#58; quasi-experimental clinical trials&#59; RCT&#58; random controlled trials&#59; SAS&#58; Short Arthritis Assessment Scale&#59; SF-36&#58; Short Form questionnaire&#59; SIGN&#58; Scottish Intercollegiate Guidelines Network&#59; VSF&#58; vascular stromal fraction&#59; VAS&#58; Visual Analogue Scale&#59; ESR&#58; erythrocyte sedimentation rate&#59; W&#58; week&#59; WOMAC&#58; Western Ontario &#38; McMaster Universities Osteoarthritis Index&#59; WORMS&#58; Whole-Organ Magnetic Resonance Imaging Score&#46;</p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Author&#44; year of publication &#40;reference&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Type of study and follow-up&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Population &#40;number&#44; percentage of women&#44; mean age&#44; eligibility&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Intervention&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Measurements of outcome&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Results&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">SIGN Quality&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Gupta et al&#46;&#44; 2016<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">12</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">RCT 12&#8239;m&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">N&#8239;&#61;&#8239;6050&#37;56&#8239;&#177;&#8239;6 yearsKellgren II-III&#59; pain which requires NSAID&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">allogenic BM MSCs &#40;Stempeucel&#169;&#41;25&#8239;&#215;&#8239;10<span class="elsevierStyleSup">6</span> &#40;2&#8239;ml&#41;&#8239;&#43;&#8239;HA n&#8239;&#61;&#8239;10&#59; Pl&#8239;&#43;&#8239;HA n&#8239;&#61;&#8239;550&#8239;&#215;&#8239;10<span class="elsevierStyleSup">6</span> &#40;2&#8239;ml&#41;&#8239;&#43;&#8239;HA n&#8239;&#61;&#8239;10&#59; Pl&#8239;&#43;&#8239;HA n&#8239;&#61;&#8239;575&#8239;&#215;&#8239;10<span class="elsevierStyleSup">6</span> &#40;4&#8239;ml&#41;&#8239;&#43;&#8239;HA n&#8239;&#61;&#8239;10&#59; Pl&#8239;&#43;&#8239;HA n&#8239;&#61;&#8239;5150&#8239;&#215;&#8239;10<span class="elsevierStyleSup">6</span> &#40;4&#8239;ml&#41;&#8239;&#43;&#8239;HA n&#8239;&#61;&#8239;10&#59; Pl&#8239;&#43;&#8239;HA n&#8239;&#61;&#8239;5HA&#8239;&#61;&#8239;Hyalgan&#174; 2&#8239;ml&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Safety&#58; PE&#44; EKG&#44; haemogram&#44; ESR&#44; BB at 1&#44; 12&#44; 24 and 48&#8239;wEfficacy&#58; VAS&#44; WOMAC&#44; ICOAP at 1&#44; 12&#44; 24 and 48&#8239;wStructural NMR &#40;0&#44; 24 and 48&#8239;w&#41;&#59; KX &#40;0&#44; 12&#44; 24&#8239;w&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Safety&#58; safe at 12&#8239;m&#46; 16&#37; post-puncture discomfort&#46; One hospitalisation due to synovial fluid Efficacy&#58; No improvement Structural No improvement&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Quality 1&#8722;Comments&#58; low sample in asymmetrical groups&#46; Low discriminatory power&#46; Short follow-up for structural efficacy&#59; heterogeneous intervention&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Lamo-Espinosa et al&#46;&#44; 2016<a class="elsevierStyleCrossRef" href="#bib0070"><span class="elsevierStyleSup">14</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">RCT 12&#8239;m&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">N&#8239;&#61;&#8239;3037&#37;61&#44;3&#8239;&#177;&#8239;5 yearsKellgren II-IV&#59; VAS&#8239;&#8805;&#8239;2&#44;5&#59; BMI 20-35&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Autologous BM MSCs Low dose&#58; 10&#8239;&#215;&#8239;10<span class="elsevierStyleSup">6</span> &#40;1&#44;5&#8239;ml&#41;&#8239;&#43;&#8239;HA n&#8239;&#61;&#8239;10High dose&#58; 150&#8239;&#215;&#8239;10<span class="elsevierStyleSup">6</span> &#40;3&#44;5&#8239;ml&#41;&#8239;&#43;&#8239;HA n&#8239;&#61;&#8239;10Control&#58; HA n&#8239;&#61;&#8239;10HA&#8239;&#61;&#8239;Hyalone&#174;&#8239;4&#8239;ml&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Safety&#58; PE&#44; haemogram&#44; BBEfficacy&#58; VAS&#44; WOMAC 0&#44; 3&#44; 6&#44; 12&#8239;m&#8220;WOMAC responders&#8221;&#8239;&#61;&#8239;&#8595;20&#37; 2 items and &#62;&#8595;10 points of total scale Structural NMR and KX &#40;0&#44; 6 and 12&#8239;m&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Safety&#58; safe at 12&#8239;m&#46; 13&#37; post-puncture discomfortEfficacy&#58; &#8595;&#8239;VAS from 3&#8239;m&#44; maximum 12&#8239;m&#46; No differences between groups&#59; &#8220;WOMAC responders&#8221; with High doses at 12&#8239;mStructural improvement at 12 months only in high doses &#40;4 WORMS points&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Quality 1&#8722;Comments&#58; low sample&#59; no masking&#59; heterogeneous groups&#59; low discriminatory power&#46; Short follow-up for structural efficacy&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Vega et al&#46;&#44; 2015<a class="elsevierStyleCrossRef" href="#bib0095"><span class="elsevierStyleSup">19</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">RCT 12&#8239;m&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">N&#8239;&#61;&#8239;3057&#37;57&#8239;&#177;&#8239;9 yearsKellgren II-IV&#59; Chronic refractory pain &#8805;&#8239;6&#8239;m&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Allogenic BM MSCs MSCs&#58; 40&#8239;&#215;&#8239;10<span class="elsevierStyleSup">6</span> &#40;1&#44;5&#8239;ml&#41; n&#8239;&#61;&#8239;15Control&#58; HA &#40;Durolane&#174; 3&#8239;ml&#41; n&#8239;&#61;&#8239;15Source MSCs&#58; 3 healthy donors from the sample&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Safety&#58; PE&#44; haemogram&#44; BBEfficacy&#58; VAS&#44; WOMAC&#44; Lequesme &#40;0&#44; 3&#44; 6&#44; 12&#8239;m&#41;Structural NMR &#40;0&#44; 6 and 12&#8239;m&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Safety&#58; safe at 12&#8239;m&#46; 53&#37; post-puncture discomfortClinical Efficacy&#58; significant improvement with VAS&#44; WOMAC&#44; Lequesme from 6&#8239;mStructural improvement at 12 months of PCI&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Quality 1&#8722;Comments&#58; low sample&#59; no masking&#59; low discriminatory power&#46; Short follow-up for structural efficacy&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Jo et al&#46;&#44; 2017<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">13</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">QCT 6&#8239;m&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">N&#8239;&#61;&#8239;1883&#37;61&#8239;&#177;&#8239;6 yearsKellgren III-IV&#59; VAS 4&#8239;&#8805;&#8239;4&#8239;m&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Autologous AT MSCs Low dose&#58; 10&#8239;&#215;&#8239;10<span class="elsevierStyleSup">6</span> &#40;3&#8239;ml&#41; &#40;n&#8239;&#61;&#8239;3&#41;Medium dose&#58; 50&#8239;&#215;&#8239;10<span class="elsevierStyleSup">6</span> &#40;3&#8239;ml&#41; &#40;n&#8239;&#61;&#8239;3&#41;High dose&#58; 100&#8239;&#215;&#8239;10<span class="elsevierStyleSup">6</span> &#40;3&#8239;ml&#41; &#40;n&#8239;&#61;&#8239;12&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Safety&#58; PE&#44; haemogram&#44; BBEfficacy&#58; VAS&#44; WOMAC&#44; KSS&#44; KOOS 0&#44; 1&#44; 2&#44; 3&#44; 6&#44; 12&#44; 24&#8239;mStructural NMR &#40;3&#44; 6 and 24&#8239;m&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Safety&#58; safe at 24&#8239;mClinical Efficacy&#58; significant improvement only with high doses&#58; VAS&#44; WOMAC&#44; KOOS and KSS &#40;maximum at 12&#8239;m&#41;Structural improvement with High doses at 6&#8239;m of interline&#44; &#8595; chondral defects and &#8593; cartilage column&#46; Then plateau&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Quality 1&#8722;Comments&#58; low sample&#59; lost data&#59; no control&#59; safety data incomplete&#59; arthroscopy bias&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Pers et al&#46;&#44; 2016<a class="elsevierStyleCrossRef" href="#bib0080"><span class="elsevierStyleSup">16</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">QCT 6&#8239;m&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">N&#8239;&#61;&#8239;1856&#37;64&#8239;&#177;&#8239;8 yearsKellgren III-IV&#59; Chronic pain &#8805;&#8239;12&#8239;m&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Autologous AT MSCs &#40;from VSF&#41;Low dose&#58; 2&#8239;&#215;&#8239;10<span class="elsevierStyleSup">6</span> &#40;5&#8239;ml&#41; &#40;n&#8239;&#61;&#8239;6&#41;Medium dose&#58; 10&#8239;&#215;&#8239;10<span class="elsevierStyleSup">6</span> &#40;5&#8239;ml&#41; &#40;n&#8239;&#61;&#8239;6&#41;High dose&#58; 50&#8239;&#215;&#8239;10<span class="elsevierStyleSup">6</span> &#40;5&#8239;ml&#41; &#40;n&#8239;&#61;&#8239;6&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Safety&#58; PE&#44; haemogram&#44; BB&#46;Efficacy&#58; VAS&#44; WOMAC&#44; PGA&#44; SAS&#44; SF-36&#44; KOOS 0&#44; 1&#8239;s&#44; 3&#8239;m&#44; 6&#8239;m&#8220;Responder&#8221;&#8239;&#61;&#8239;&#8595;20&#37; VAS and WOMACStructural NMR &#40;0&#44; 4&#8239;m&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Safety&#58; safe 22&#37; post-puncture discomfortClinical efficacy&#58; Significant improvement from 1&#46;&#170; only with Low doses&#58; VAS&#44; WOMAC&#44; KOOS and responders &#40;maximum at 3&#8239;m&#41;Structural improvement inconclusive&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Quality 1&#8722;Comments&#58; low sample&#59; lost data&#59; no control&#59; heterogeneous groups&#59; NMR results incomplete&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Song et al&#46;&#44; 2016<a class="elsevierStyleCrossRef" href="#bib0090"><span class="elsevierStyleSup">18</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">QCT 24&#8239;m&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">N&#8239;&#61;&#8239;1878&#37;55&#8239;&#177;&#8239;10 yearsKellgren II-III&#59; VAS&#8239;&#8805;&#8239;4&#8239;&#62;&#8239;4&#8239;m&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Autologous AT MSCs PHASE I &#40;2 doses separated by 3&#8239;w&#41;Low dose&#58; 10&#8239;&#215;&#8239;10<span class="elsevierStyleSup">6</span> &#40;3&#8239;ml&#41; &#40;n&#8239;&#61;&#8239;6&#41;Medium dose&#58; 20&#8239;&#215;&#8239;10<span class="elsevierStyleSup">6</span> &#40;3&#8239;ml&#41; &#40;n&#8239;&#61;&#8239;6&#41;High dose&#58; 50&#8239;&#215;&#8239;10<span class="elsevierStyleSup">6</span> &#40;3&#8239;ml&#41; &#40;n&#8239;&#61;&#8239;6&#41;PHASE IIa &#40;additional dose 50&#8239;&#215;&#8239;10<span class="elsevierStyleSup">6</span> after one year&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Safety&#58; PE&#44; EKG&#44; haemogram&#44; ESR&#44; BB every 2&#8239;s&#8239;&#215;&#8239;12&#8239;mEfficacy&#58; WOMAC&#44; NRS-11&#44; SF-36 &#40;0&#44; 12&#44; 24&#44; 48&#44; 72&#44; 96&#8239;w&#41;Structural NMR &#40;0&#44; 12&#44; 24&#44; 48&#44; 72&#44; 96&#8239;w&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Safety&#58; safe 44&#37; post-puncture discomfortClinical efficacy&#58; consistent only with high doses&#46; NRS-11 improvement from 3-24&#8239;m&#59; WOMAC from 6 to 12&#8239;m&#44; then plateauStructural increase thickness of cartilage greater with high doses&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Quality 1&#8722;Comments&#58; potential multi-dose benefit&#59; low sample&#59; no control&#59; results biased for a efficacy&#59; heterogeneous groups&#59; confusing methodology&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Al-Najar et al&#46;&#44; 2017<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">11</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">QCT 24&#8239;m&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">N&#8239;&#61;&#8239;1378&#37;50&#8239;&#177;&#8239;10 yearsKellgren II-III&#59; Chronic pain &#8805;&#8239;6&#8239;m&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Autologous AT MSCs Two doses 30&#46;5&#8239;&#215;&#8239;10<span class="elsevierStyleSup">6</span> &#40;5&#8239;ml&#41; separated by 4 w&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Safety&#58; PE &#40;1&#44; 2&#44; 4&#44; 12&#8239;s and then every 6&#8239;m&#41;&#44; haemogram and BB &#40;3&#44; 24&#8239;m&#41;Efficacy&#58; KOOS &#40;1&#44; 2&#44; 4&#44; 6&#44; 12&#44; 24&#8239;m&#41;Structural NMR &#40;6&#44; 12&#8239;m&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Safety&#58; safe 23&#37; post-puncture discomfortClinical efficacy&#58; improvement KOSS from 6 to 12&#8239;m&#44; then plateauStructural increase of cartilage thickness at 12&#8239;m&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Quality 1&#8722;Comments&#58; very low sample and biased for efficacy&#59; no control group&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Orozco et al&#46;&#44; 2013<a class="elsevierStyleCrossRef" href="#bib0075"><span class="elsevierStyleSup">15</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">QCT 12&#8239;m&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">N&#8239;&#61;&#8239;1250&#37;49&#8239;&#177;&#8239;5 yearsKellgren II-IV&#59; Refractory pain &#8805;&#8239;6&#8239;m&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Autologous BM MSCs Single dose 40&#8239;&#215;&#8239;10<span class="elsevierStyleSup">6</span> &#40;8&#8239;ml&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Safety&#58; PE&#44; haemogram&#44; BB &#40;1&#8239;s&#44; 3&#44; 6&#44; 12&#8239;m&#41;Efficacy&#58; VAS &#40;0&#44; 3&#44; 6&#44; 12&#8239;m&#41;&#44; WOMAC and Lequesme &#40;0 y 12&#8239;m&#41;Structural NMR &#40;&#46; 6 and 12&#8239;m&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Safety&#58; safe at 12&#8239;m&#46; 50&#37; post-puncture discomfortClinical efficacy&#58; significant VAS improvement from 3&#8239;m&#44; maximum at 12&#8239;m&#46; Improvement WOMAC&#44; Lequesme at 12&#8239;mStructural improvement at 6 and 12&#8239;m of PCI&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Quality 1&#8722;Comments&#58; improvement and safety maintained in follow-up at 24&#8239;m&#46;Very low sample and biased for efficacy&#59; no control&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Soler et al&#46;&#44; 2015<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">17</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">QCT 12&#8239;m&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">N&#8239;&#61;&#8239;1560&#37;52&#8239;&#177;&#8239;5 yearsKellgren II-III&#59; Chronic mechanical pain&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Autologous BM MSCs Single dose&#58; 40&#46;9&#8239;&#215;&#8239;10<span class="elsevierStyleSup">6</span>&#8239;&#177;&#8239;&#46;4&#8239;&#215;&#8239;10<span class="elsevierStyleSup">6</span> &#40;10&#46;0&#8239;&#177;&#8239;&#46;3&#8239;ml&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Safety&#58; PE&#44; haemogram&#44; BB &#40;1&#8239;w&#44; 3&#44; 6&#44; 12&#8239;m&#41;Efficacy&#58; VAS &#40;0&#44; 3&#44; 6&#44; 12&#8239;m&#41;&#44; HAQ pain&#44; SF-36&#44; WOMAC and Lequesme &#40;0&#44; 6 and 12&#8239;m&#41;Structural NMR&#44; T2 mapping of composition of collagen of the cartilaginous matrix &#40;&#46; 6 and 12&#8239;m&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Safety&#58; safe at 12&#8239;m&#46; 60&#37; post-puncture discomfort&#46; Lumbago 27&#37;Clinical efficacy&#58; significant VAS improvement from 8 d&#44; maximum to 12&#8239;m&#46; Improvement WOMAC&#44; Lequesme at 12&#8239;m&#46; No improvement SF-36Structural significant reduction of T2 map at 12 months&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Quality 1&#8722;Comments&#58; improvement and safety maintained at 4 years&#46; Better in patient candidates with moderate osteoarthritis&#46; Very low sample and biased for efficacy&#59; no control group&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab2818054.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Summary of evidence</p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:31 [
            0 => array:3 [
              "identificador" => "bib0005"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Mesenchymal stem cell-based therapy of osteoarthritis&#58; current knowledge and future perspectives"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "C&#46;R&#46; Harrell"
                            1 => "B&#46;S&#46; Markovic"
                            2 => "C&#46; Fellabaum"
                            3 => "A&#46; Arsenijevic"
                            4 => "V&#46; Volarevic"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.biopha.2018.11.099"
                      "Revista" => array:7 [
                        "tituloSerie" => "Biomed Pharmacother&#46;"
                        "fecha" => "2019"
                        "volumen" => "109"
                        "paginaInicial" => "2318"
                        "paginaFinal" => "2326"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30551490"
                            "web" => "Medline"
                          ]
                        ]
                        "itemHostRev" => array:3 [
                          "pii" => "S0140673620301835"
                          "estado" => "S300"
                          "issn" => "01406736"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0010"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Mesenchymal stem cell and regenerative medicine&#58; regeneration versus immunomodulatory challenges"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "S&#46; Law"
                            1 => "S&#46; Chaudhuri"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Stem Cells&#46;"
                        "fecha" => "2013"
                        "volumen" => "2"
                        "paginaInicial" => "22"
                        "paginaFinal" => "38"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23671814"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0015"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Direct transplantation of mesenchymal stem cells into the knee joints of Hartley strain guinea pigs with spontaneous osteoarthritis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46; Sato"
                            1 => "K&#46; Uchida"
                            2 => "H&#46; Nakajima"
                            3 => "T&#46; Miyazaki"
                            4 => "A&#46;R&#46; Guerrero"
                            5 => "S&#46; Watanabe"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1186/ar3735"
                      "Revista" => array:5 [
                        "tituloSerie" => "Arthritis Res Ther&#46;"
                        "fecha" => "2012"
                        "volumen" => "14"
                        "paginaInicial" => "R31"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22314040"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0020"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Stem cell injections in knee osteoarthritis&#58; a systematic review of the literature"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "H&#46;I&#46; Pas"
                            1 => "M&#46; Winters"
                            2 => "H&#46;J&#46; Haisma"
                            3 => "M&#46;J&#46; Koenis"
                            4 => "J&#46;L&#46; Tol"
                            5 => "M&#46;H&#46; Moen"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1136/bjsports-2016-096793"
                      "Revista" => array:6 [
                        "tituloSerie" => "Br J Sports Med&#46;"
                        "fecha" => "2017"
                        "volumen" => "51"
                        "paginaInicial" => "1125"
                        "paginaFinal" => "1133"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28258177"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0025"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Efficacy of mesenchymal stem cells injection for the management of knee osteoarthritis&#58; a systematic review and meta-analysis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "P&#46; Xia"
                            1 => "X&#46; Wang"
                            2 => "Q&#46; Lin"
                            3 => "X&#46; Li"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1007/s00264-015-2785-8"
                      "Revista" => array:6 [
                        "tituloSerie" => "Int Orthop&#46;"
                        "fecha" => "2015"
                        "volumen" => "39"
                        "paginaInicial" => "2363"
                        "paginaFinal" => "2372"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25944079"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0030"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Nomenclature inconsistency and selective outcome reporting hinder understanding of stem cell therapy for the knee"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "I&#46;A&#46; Jones"
                            1 => "X&#46; Chen"
                            2 => "D&#46; Evseenko"
                            3 => "C&#46;T&#46; Vangsness Jr"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.2106/JBJS.17.01474"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Bone Joint Surg Am&#46;"
                        "fecha" => "2019"
                        "volumen" => "101"
                        "paginaInicial" => "186"
                        "paginaFinal" => "195"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30653050"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0035"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Adipose stem cells&#58; biology and clinical applications for tissue repair and regeneration"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "L&#46;E&#46; Kokai"
                            1 => "K&#46; Marra"
                            2 => "J&#46;P&#46; Rubin"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.trsl.2013.11.009"
                      "Revista" => array:6 [
                        "tituloSerie" => "Transl Res&#46;"
                        "fecha" => "2014"
                        "volumen" => "163"
                        "paginaInicial" => "399"
                        "paginaFinal" => "408"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24361334"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0040"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Comparative analysis of mesenchymal stem cells from bone marrow&#44; umbilical cord blood&#44; or adipose tissue"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "S&#46; Kern"
                            1 => "H Eichler"
                            2 => "J Stoeve"
                            3 => "H&#46; Kl&#252;ter"
                            4 => "K&#46; Bieback"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:2 [
                    0 => array:2 [
                      "doi" => "10.1634/stemcells.2005-0342"
                      "Revista" => array:6 [
                        "tituloSerie" => "Stem Cells&#46;"
                        "fecha" => "2006"
                        "volumen" => "24"
                        "paginaInicial" => "1294"
                        "paginaFinal" => "1301"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16410387"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                    1 => array:2 [
                      "doi" => "10.1634/stemcells.2005-0342"
                      "WWW" => array:1 [
                        "link" => "https&#58;&#47;&#47;doi&#46;org&#47;10&#46;1634&#47;stemcells&#46;2005-0342"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib0045"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Minimal criteria for defining multipotent mesenchymal stromal cells&#46; The International Society for Cellular Therapy position statement"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46; Dominici"
                            1 => "K&#46; Le Blanc"
                            2 => "I&#46; Mueller"
                            3 => "I&#46; Slaper-Cortenbach"
                            4 => "F&#46; Marini"
                            5 => "D&#46; Krause"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1080/14653240600855905"
                      "Revista" => array:6 [
                        "tituloSerie" => "Cytotherapy&#46;"
                        "fecha" => "2006"
                        "volumen" => "8"
                        "paginaInicial" => "315"
                        "paginaFinal" => "317"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16923606"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib0050"
              "etiqueta" => "10"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Forming guideline recommendations&#46; SIGN 50"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "Network SIG"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Libro" => array:1 [
                        "fecha" => "2008"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            10 => array:3 [
              "identificador" => "bib0055"
              "etiqueta" => "11"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Intra-articular injection of expanded autologous bone marrow mesenchymal cells in moderate and severe knee osteoarthritis is safe&#58; a phase I&#47;II study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46; Al-Najar"
                            1 => "H&#46; Khalil"
                            2 => "J&#46; Al-Ajlouni"
                            3 => "E&#46; Al-Antary"
                            4 => "M&#46; Hamdan"
                            5 => "R&#46; Rahmeh"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1186/s13018-017-0689-6"
                      "Revista" => array:5 [
                        "tituloSerie" => "J Orthop Surg Res&#46;"
                        "fecha" => "2017"
                        "volumen" => "12"
                        "paginaInicial" => "190"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29233163"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            11 => array:3 [
              "identificador" => "bib0060"
              "etiqueta" => "12"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Efficacy and safety of adult human bone marrow-derived&#44; cultured&#44; pooled&#44; allogeneic mesenchymal stromal cells &#40;Stempeucel&#174;&#41;&#58; preclinical and clinical trial in osteoarthritis of the knee joint"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "P&#46;K&#46; Gupta"
                            1 => "A&#46; Chullikana"
                            2 => "M&#46; Rengasamy"
                            3 => "N&#46; Shetty"
                            4 => "V&#46; Pandey"
                            5 => "V&#46; Agarwal"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1186/s13075-016-1195-7"
                      "Revista" => array:6 [
                        "tituloSerie" => "Arthritis Res Ther&#46;"
                        "fecha" => "2016"
                        "volumen" => "18"
                        "paginaInicial" => "301"
                        "paginaFinal" => "319"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27993154"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            12 => array:3 [
              "identificador" => "bib0065"
              "etiqueta" => "13"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Intra-articular injection of mesenchymal stem cells for the treatment of osteoarthritis of the knee&#58; a proof-of-concept clinical trial"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "C&#46;H&#46; Jo"
                            1 => "Y&#46;G&#46; Lee"
                            2 => "W&#46;H&#46; Shin"
                            3 => "H&#46; Kim"
                            4 => "J&#46;W&#46; Chai"
                            5 => "E&#46;C&#46; Jeong"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/stem.1634"
                      "Revista" => array:6 [
                        "tituloSerie" => "Stem Cells&#46;"
                        "fecha" => "2014"
                        "volumen" => "32"
                        "paginaInicial" => "1254"
                        "paginaFinal" => "1266"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24449146"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            13 => array:3 [
              "identificador" => "bib0070"
              "etiqueta" => "14"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Intra-articular injection of two different doses of autologous bone marrow mesenchymal stem cells versus hyaluronic acid in the treatment of knee osteoarthritis&#58; multicenter randomized controlled clinical trial &#40;phase I&#47;II&#41;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46; Lamo-Espinosa"
                            1 => "G&#46; Mora"
                            2 => "J&#46; Blanco"
                            3 => "F&#46; Granero-Molt&#243;"
                            4 => "J&#46; Nu&#241;ez-C&#243;rdoba"
                            5 => "C&#46; S&#225;nchez-Echenique"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1186/s12967-016-0998-2"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Transl Med&#46;"
                        "fecha" => "2016"
                        "volumen" => "14"
                        "paginaInicial" => "246"
                        "paginaFinal" => "255"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27565858"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            14 => array:3 [
              "identificador" => "bib0075"
              "etiqueta" => "15"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Treatment of knee osteoarthritis with autologous mesenchymal stem cells&#58; a pilot study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "L&#46; Orozco"
                            1 => "A&#46; Munar"
                            2 => "R&#46; Soler"
                            3 => "M&#46; Alberca"
                            4 => "F&#46; Soler"
                            5 => "M&#46; Huguet"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1097/TP.0b013e318291a2da"
                      "Revista" => array:6 [
                        "tituloSerie" => "Transplantation&#46;"
                        "fecha" => "2013"
                        "volumen" => "95"
                        "paginaInicial" => "1535"
                        "paginaFinal" => "1541"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23680930"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            15 => array:3 [
              "identificador" => "bib0080"
              "etiqueta" => "16"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Adipose mesenchymal stromal cell-based therapy for severe osteoarthritis of the knee&#58; a phase I dose-escalation trial"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "Y&#46;M&#46; Pers"
                            1 => "L&#46; Rackwitz"
                            2 => "R&#46; Ferreira"
                            3 => "O&#46; Pullig"
                            4 => "C&#46; Delfour"
                            5 => "F&#46; Barry"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.5966/sctm.2015-0245"
                      "Revista" => array:6 [
                        "tituloSerie" => "Stem Cells Transl Med&#46;"
                        "fecha" => "2016"
                        "volumen" => "5"
                        "paginaInicial" => "847"
                        "paginaFinal" => "856"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27217345"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            16 => array:3 [
              "identificador" => "bib0085"
              "etiqueta" => "17"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Final results of a phase I-II trial using ex vivo expanded autologous mesenchymal stromal cells for the treatment of osteoarthritis of the knee confirming safety and suggesting cartilage regeneration"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "R&#46; Soler"
                            1 => "L&#46; Orozco"
                            2 => "A&#46; Munar"
                            3 => "M&#46; Huguet"
                            4 => "R&#46; Lopez"
                            5 => "J&#46; Vives"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.knee.2015.08.013"
                      "Revista" => array:6 [
                        "tituloSerie" => "Knee&#46;"
                        "fecha" => "2016"
                        "volumen" => "23"
                        "paginaInicial" => "647"
                        "paginaFinal" => "654"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26783191"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            17 => array:3 [
              "identificador" => "bib0090"
              "etiqueta" => "18"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Human adipose-derived mesenchymal stem cells for osteoarthritis&#58; a pilot study with long-term follow-up and repeated injections"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "Y&#46; Song"
                            1 => "H&#46; Du"
                            2 => "C&#46; Dai"
                            3 => "L&#46; Zhang"
                            4 => "S&#46; Li"
                            5 => "D&#46;J&#46; Hunter"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.2217/rme-017-0152"
                      "Revista" => array:6 [
                        "tituloSerie" => "Regen Med&#46;"
                        "fecha" => "2018"
                        "volumen" => "13"
                        "paginaInicial" => "295"
                        "paginaFinal" => "307"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29417902"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            18 => array:3 [
              "identificador" => "bib0095"
              "etiqueta" => "19"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Treatment of knee osteoarthritis with allogeneic bone marrow mesenchymal stem cells&#58; a randomized controlled trial"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "A&#46; Vega"
                            1 => "M&#46;A&#46; Martin-Ferrero"
                            2 => "F&#46; del Canto"
                            3 => "M&#46; Alberca"
                            4 => "V&#46; Garcia"
                            5 => "A&#46; Munar"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1097/TP.0000000000000678"
                      "Revista" => array:6 [
                        "tituloSerie" => "Transplantation&#46;"
                        "fecha" => "2015"
                        "volumen" => "99"
                        "paginaInicial" => "1681"
                        "paginaFinal" => "1690"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25822648"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            19 => array:3 [
              "identificador" => "bib0100"
              "etiqueta" => "20"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The effect of intra-articular injection of autologous bone marrow stem cells on pain and knee function in patients with osteoarthritis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "D&#46; Garay-Mendoza"
                            1 => "L&#46; Villarreal-Mart&#237;nez"
                            2 => "A&#46; Garza-Bedolla"
                            3 => "D&#46;M&#46; P&#233;rez-Garza"
                            4 => "C&#46; Acosta-Olivo"
                            5 => "F&#46; Vilchez-Cavazos"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/756-185X.13139"
                      "Revista" => array:6 [
                        "tituloSerie" => "Int J Rheum Dis&#46;"
                        "fecha" => "2018"
                        "volumen" => "21"
                        "paginaInicial" => "140"
                        "paginaFinal" => "147"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28752679"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            20 => array:3 [
              "identificador" => "bib0105"
              "etiqueta" => "21"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A prospective&#44; single-blind&#44; placebo-controlled trial of bone marrow aspirate concentrate for knee osteoarthritis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "S&#46;A&#46; Shapiro"
                            1 => "S&#46;E&#46; Kazmerchak"
                            2 => "M&#46;G&#46; Heckman"
                            3 => "A&#46;C&#46; Zubair"
                            4 => "MI O&#8217;Connor"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1177/0363546516662455"
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Sports Med&#46;"
                        "fecha" => "2017"
                        "volumen" => "45"
                        "paginaInicial" => "82"
                        "paginaFinal" => "90"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27566242"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            21 => array:3 [
              "identificador" => "bib0110"
              "etiqueta" => "22"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Treatment of knee osteoarthritis with autologous expanded bone marrow mesenchymal stem cells&#58; 50 cases clinical and MRI results at one year follow-up"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "R&#46;M&#46; Soler Rich"
                            1 => "A&#46; Soler Romagosa"
                            2 => "F&#46; Peirau"
                            3 => "X&#46; Huguet"
                            4 => "M&#46; Alberca"
                            5 => "M&#46; S&#225;nchez"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.4172/2157-7633.1000285"
                      "Revista" => array:5 [
                        "tituloSerie" => "J Stem Cell Res Ther&#46;"
                        "fecha" => "2015"
                        "volumen" => "5"
                        "paginaInicial" => "285"
                        "paginaFinal" => "292"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            22 => array:3 [
              "identificador" => "bib0115"
              "etiqueta" => "23"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Intra-articular implantation of autologous bone marrow-derived mesenchymal stromal cells to treat knee osteoarthritis&#58; a randomized&#44; triple-blind&#44; placebo-controlled phase 1&#47;2 clinical trial"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46; Emadedin"
                            1 => "N&#46; Labibzadeh"
                            2 => "M&#46;G&#46; Liastani"
                            3 => "A&#46; Karimi"
                            4 => "N&#46; Jaroughi"
                            5 => "T&#46; Bolurieh"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.jcyt.2018.08.005"
                      "Revista" => array:6 [
                        "tituloSerie" => "Cytotherapy&#46;"
                        "fecha" => "2018"
                        "volumen" => "20"
                        "paginaInicial" => "1238"
                        "paginaFinal" => "1246"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30318332"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            23 => array:3 [
              "identificador" => "bib0120"
              "etiqueta" => "24"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Safety&#44; tolerability and efficacy of intra-articular Progenza in knee osteoarthritis&#58; a randomized double-blind placebo-controlled single ascending dose study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "D&#46; Kuah"
                            1 => "S&#46; Sivell"
                            2 => "T&#46; Longworth"
                            3 => "K&#46; James"
                            4 => "A&#46; Guermazi"
                            5 => "F&#46; Cicuttini"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1186/s12967-018-1420-z"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Transl Med&#46;"
                        "fecha" => "2018"
                        "volumen" => "16"
                        "paginaInicial" => "49"
                        "paginaFinal" => "62"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29510712"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            24 => array:3 [
              "identificador" => "bib0125"
              "etiqueta" => "25"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Intra-articular injection of two different doses of autologous bone marrow mesenchymal stem cells versus hyaluronic acid in the treatment of knee osteoarthritis&#58; long-term follow up of a multicenter randomized controlled clinical trial &#40;phase I&#47;II&#41;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46; Lamo-Espinosa"
                            1 => "G&#46; Mora"
                            2 => "J&#46; Blanco"
                            3 => "F&#46; Granero-Molt&#243;"
                            4 => "J&#46; N&#250;&#241;ez-C&#243;rdoba"
                            5 => "S&#46; L&#243;pez-El&#237;o"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:4 [
                        "tituloSerie" => "J Transl Med&#46;"
                        "fecha" => "2018"
                        "volumen" => "16"
                        "paginaInicial" => "2013"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            25 => array:3 [
              "identificador" => "bib0130"
              "etiqueta" => "26"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Adipose-derived mesenchymal stem cell therapy in the treatment of knee osteoarthritis&#58; a randomized controlled trial"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46; Freitag"
                            1 => "D&#46; Bates"
                            2 => "J&#46; Wickham"
                            3 => "K&#46; Shah"
                            4 => "L&#46; Huguenin"
                            5 => "A&#46; Tenen"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.2217/rme-2018-0161"
                      "Revista" => array:6 [
                        "tituloSerie" => "Regen Med&#46;"
                        "fecha" => "2019"
                        "volumen" => "14"
                        "paginaInicial" => "213"
                        "paginaFinal" => "230"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30762487"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            26 => array:3 [
              "identificador" => "bib0135"
              "etiqueta" => "27"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The role of stromal stem cells in tissue regeneration and wound repair"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "T&#46;S&#46; Stappenbeck"
                            1 => "H&#46; Miyoshi"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1126/science.1172687"
                      "Revista" => array:6 [
                        "tituloSerie" => "Science&#46;"
                        "fecha" => "2009"
                        "volumen" => "324"
                        "paginaInicial" => "1666"
                        "paginaFinal" => "1669"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19556498"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            27 => array:3 [
              "identificador" => "bib0140"
              "etiqueta" => "28"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Second-look arthroscopic evaluation of cartilage lesions after mesenchymal stem cell implantation in osteoarthritic knees"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "Y&#46;G&#46; Koh"
                            1 => "Y&#46;J&#46; Choi"
                            2 => "O&#46;R&#46; Kwon"
                            3 => "Y&#46;S&#46; Kim"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1177/0363546514529641"
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Sports Med&#46;"
                        "fecha" => "2014"
                        "volumen" => "42"
                        "paginaInicial" => "1628"
                        "paginaFinal" => "1637"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24743139"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            28 => array:3 [
              "identificador" => "bib0145"
              "etiqueta" => "29"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Safety of intra-articular cell-therapy with culture-expanded stem cells in humans&#58; a systematic literature review"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "C&#46;M&#46; Peeters"
                            1 => "M&#46;J&#46; Leijs"
                            2 => "M Reijman"
                            3 => "GJ van Osch"
                            4 => "PK Bos"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Osteoarthr Cartil&#46;"
                        "fecha" => "2013"
                        "volumen" => "21"
                        "paginaInicial" => "1465"
                        "paginaFinal" => "1473"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            29 => array:3 [
              "identificador" => "bib0150"
              "etiqueta" => "30"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Umbilical cord-derived mesenchymal stromal cells &#40;MSCs&#41; for knee osteoarthritis&#58; repeated MSC dosing is superior to a single MSC dose and to hyaluronic acid in a controlled randomized phase I&#47;II trial"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46; Matas"
                            1 => "M&#46; Orrego"
                            2 => "D&#46; Amenabar"
                            3 => "C&#46; Infante"
                            4 => "R&#46; Tapia-Limonchi"
                            5 => "M&#46;I&#46; Cadiz"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:2 [
                    0 => array:2 [
                      "doi" => "10.1002/sctm.18-0053"
                      "Revista" => array:6 [
                        "tituloSerie" => "Stem Cells Transl Med&#46;"
                        "fecha" => "2019"
                        "volumen" => "8"
                        "paginaInicial" => "215"
                        "paginaFinal" => "224"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30592390"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                    1 => array:2 [
                      "doi" => "10.1002/sctm.18-0053"
                      "WWW" => array:1 [
                        "link" => "https&#58;&#47;&#47;doi&#46;org&#47;10&#46;1002&#47;sctm&#46;18-0053"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            30 => array:3 [
              "identificador" => "bib0155"
              "etiqueta" => "31"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Safety and efficacy of allogenic placental mesenchymal stem cells for treating knee osteoarthritis&#58; a pilot study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "S&#46; Khalifeh Soltani"
                            1 => "B&#46; Forogh"
                            2 => "N&#46; Ahmadbeigi"
                            3 => "H&#46; Hadizadeh Kharazi"
                            4 => "K&#46; Fallahzadeh"
                            5 => "L&#46; Kashani"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.jcyt.2018.11.003"
                      "Revista" => array:6 [
                        "tituloSerie" => "Cytotherapy&#46;"
                        "fecha" => "2019"
                        "volumen" => "21"
                        "paginaInicial" => "54"
                        "paginaFinal" => "63"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30522806"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/21735743/0000001800000001/v1_202201261003/S2173574321001106/v1_202201261003/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "8383"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Review Article"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/21735743/0000001800000001/v1_202201261003/S2173574321001106/v1_202201261003/en/main.pdf?idApp=UINPBA00004M&text.app=https://reumatologiaclinica.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574321001106?idApp=UINPBA00004M"
]

Article information

ISSN: 21735743
Original language: English

DOI:10.1016/j.reumae.2020.10.001

The statistics are updated each day

Year/Month	Html	Pdf	Total

2024 November	10	8	18
2024 October	44	28	72
2024 September	44	19	63
2024 August	68	27	95
2024 July	64	39	103
2024 June	94	36	130
2024 May	82	36	118
2024 April	113	30	143
2024 March	92	34	126
2024 February	79	45	124
2024 January	70	32	102
2023 December	90	49	139
2023 November	55	36	91
2023 October	86	35	121
2023 September	157	49	206
2023 August	165	31	196
2023 July	47	30	77
2023 June	43	34	77
2023 May	53	33	86
2023 April	46	35	81
2023 March	76	42	118
2023 February	54	26	80
2023 January	40	17	57
2022 December	94	49	143
2022 November	75	34	109
2022 October	84	49	133
2022 September	86	49	135
2022 August	78	48	126
2022 July	63	45	108

Show all

Indexed in:

Follow us:

Subscribe:

Statistics

Indexed in:

Follow us:

Subscribe:

Statistics

Subscribe to our newsletter